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Abstract 
Sampling through extracellular space has always been a challenge. Traditional methods, such as 
push-pull perfusion, microdialysis and direct sampling, are not suitable for sampling through thin 
slice cultures; since they all involve probe implantation. Through this research we developed a 
novel sampling method based on electroosmosis. By taking advantage of the natural ζ-potential 
in an organotypic hippocampus slice culture, an electroosmotic flow was successfully invoked 
within the extracellular space by applying an electric field. This flow was used to draw the 
physiological fluid from the slice culture. We have characterized this method by examining the 
flow rate, sampling bias, internal standard and damage caused during sampling. Coupled with a 
capillary high performance liquid chromatography (HPLC) and an electrochemical detection, 
this novel sampling method was applied to study enkephalin hydrolysis by e ctoenzymes 
distributed in the hippocampus area. The results showed not only the feasibility and efficiency of 
the electroosmotic sampling technique in extracting extracellular material, but also its potential 
for studying ectopeptidase activity. A capillary Taylor reactor was employed to perform post-
column reactions in the electrochemical detection. This reactor shares pressure with the capillary 
column and adds band-spreading, which reduce separation efficiency. We quantitatively 
evaluated this effect and gave a set of optimal and practical conditions.  
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Chapter 1 Introduction 
 
Neuropeptides play key roles in the function of brain and peripheral nervous system such as pain 
and learning1. They are mainly inactivated by ectopeptidases which are membrane bound with 
their active sites facing extracellular space. These enzymes cleave active neuropeptides into 
inactive fragments2-4. For example, thyrotropin-releasing hormone (TRH), an important 
extracellular signal substance, is inactivated after released by an ectoenzyme which locates 
preferentially on ne uronal cells in the brain and on l actotrophic pituitary cells5.  Angiotensin-
converting enzyme (ACE), aminopeptidase N (APN) and endopeptidase 24.11 have been 
determined to regulate the metabolism and biological function of CRF (the corticotrophin-
releasing factor)6.  Ectopeptidases are also involved in the hydrolysis of opioid peptides such as 
enkephalins in the brain, kidney and intestines7. Moreover, membrane peptidases play important 
roles in cell activation, proliferation and communication. Thus, in-deep understanding of 
ectopeptidase activity is necessary for understanding both normal and pathological brain function 
as well as for designing novel strategies for drug development. A major concern of the analysis 
of ectopeptidase activity is tissue fractionation or damage which releases the cytosolic peptidases 
that interfere with the analysis by contributing to peptide degradation. Reliable analysis of 
ectopeptidase activity requires intact cells or tissues.  
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1.1 Current Methods in Peptidase Analysis 
Most of our knowledge of peptidases came from the analysis of tissue extracts, homogenate or 
fraction by determination of peptide fragment using HPLC8, 9 or standard enzyme methods 
(fluorogenic substrate)10, 11. Although these methods offer experimental simplicity, they suffer 
the interference from cytosolic peptidases and membrane bound peptidases facing intracellularly 
which degrade peptide also. For this reason, conventional methods are not favorable for 
ectopeptidase analysis. Another limitation of these methods is the lack of spatial resolution.  A 
good spatial resolution is necessary in some cases. For instance, enkephalin-degrading activity 
has a co nsiderable variation across the human brain12. Another common method is to simply 
incubate the target tissue culture into substrate solution and then analyze the solution. This 
method relies on slow diffusion thus resulting in a poor time resolution.  
Microdialysis is actively used in peptidase analysis. Peptidase activity has been a concern 
in microdialysis experiments. Microdialysis sampling of peptides is improved in the presence of 
peptidase inhibitors13-19. Continuous sampling of neuropeptides and monitoring their 
concentrations in exctracellular space help us understand the ectopeptidase activity. 
Quantification of neuropeptides in dialysates is challenging due to their low extracellular 
concentrations (low pM range), their low microdialysis efficiencies, the need for acceptable 
temporal resolution, the small sample volumes, the complexity of cell matrix and the tendency of 
peptides to stick to glass and the polymeric membrane of  a microdialysis probe20.   
Many efforts have been made to overcome these problems.  A number of LC-MS/MS and 
microdialysis parameters have been optimized to achieve maximum sensitivity so that in vivo 
neuropeptide release can be investigated20. Microdialysis sampling combined with LC-ESI-MS 
detection allowed for in situ determination of the enzymatic activity of a protease external to the 
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microdialysis probe when using different peptide-based substrates21. Non-specific binding of 
peptides to the tubing and probe membrane limits microdialysis to evaluate the absolute 
extracellular concentrations. A systematic approach for reducing and evaluating the non-specific 
binding has strengthened the applicability of microdialysis22. However, this evaluation has to be 
made in vitro in each individual case before in vivo microdialysis. It is complicated since a range 
of additives in perfusion fluid and tubing material has to be tested in vitro. New tubing material, 
probe membrane and additives might improve or resolve the non-specific binding issues. 
Microdialysis is an established technique for sampling small molecules through extracellular 
space but not for collecting larger molecules. Using a new “vent” probe with a push-pull 
perfusion system, pathophysiologically important macromolecules such as Aβ peptides are 
successfully sampled from the brain of a free-moving mouse with a constant recovery rate23. 
This novel system contains a polyethylene membrane probe (1000 kDa MWCO) and a push 
syringe and pull peristaltic pump simultaneously operated at various flow rates, which allows 
rapid equalization of the pressure inside the probe and results in constant recovery rates.  
Overall, microdialysis is a well established and powerful technique. It f inds its 
application in the peptidase or protease activity due to its capacity in real-time observation of 
concentration changes in extracellular space24-27. However, microdialysis also has some 
disadvantages. The time resolution in many cases is over 10 min as the flow rate of perfusate is 
low (usually less than 2 µL/min). The low time resolution is also related to the detection limits of 
the coupled analytical method. In ordinary conditions, peptide concentration in the dialysate is 
around 5% or less. Detection becomes much more challenging due to such dilution. Furthermore, 
the spatial resolution of microdialysis is limited by the length of the semipermeable membrane 
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which is usually 2-4 mm. Implanting the probes causes a penetration injury in the brain tissue28-
29.   
 1.2 Our Approach 
We have developed a novel sampling method based on electroosmosis, which is more suitable 
for neurochemical extraction from the extracellular space in slice cultures. We demonstrated the 
feasibility and advantages of this electroosmosis sampling in ectopeptidase activity studies when 
coupled with HPLC-EC.  In this research, we used organotypic hippocampal slice culture as an 
experimental model and applied Leu-enkephaline (YGGFL) degradation as an experimental 
probe. The following gives a detailed background related to this study. 
1.2.1 Organotypic Hippocampal Slice Culture (OHSC) 
Slices derived from various brain regions are predominant in vitro preparations for studying the 
physiological and pharmacological properties of neuronal circuits. They are easy to prepare and 
they maintain the cytoarchitecture of the tissue of origin. However, acute slices are short-lived. 
For experiments that require long-term survival of the preparations, such as studies involving 
chronic application of neural connectivity, development of neural connectivity, fiber growth and 
synaptic transmission in co-cultures derived from different brain areas, acute slices are obviously 
not suitable. Thus, slice cultures have become an attractive alternative and a n ecessary 
complement to acute slices. Procedures have been developed to sustain brain tissues in culture. 
The most popular ones are the roller tube and interface techniques. Both produce organotypic 
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culture, a term introduced initially for neuronal cultures by C rain30, 31 to describe the 
cytoarchitecture of explants which mimic their in situ counterparts. 
Both techniques start from acute slices with desired thickness. In the roller tube technique 
32-34 a slice is attached onto a glass coverslip by means of a chicken plasma clot or sometimes a 
collagen matrix and then put into a plastic test tube with enough medium. The test tube is placed 
in a roller drum. This continuous slow rotation ensures feeding and oxygenation of the culture 
because the culture is immersed in the medium for half a circle and covered by a film of medium 
for the other half circle in dry air. The culture is incubated at 36 ± 0.5 °C. Medium is exchanged 
weekly. In the interface preparation35, a slice is positioned on a  sterile, transparent and low 
protein binding PTFE porous membrane with culture medium underneath it. The insert is then 
put into an incubator with a temperature set to 36 °C and with a 5% CO2-enriched atmosphere. 
The porous membrane surface provides an air/medium interface. Slices obtain sufficient nutrient 
and remain well exposed to air at the same time. The medium is exchanged twice a week.    
Slice cultures yielded from both procedures share some characteristics: they duplicate the 
cytoarchitecture of their in vivo counterparts; slice cultures are flatten in medium; even after 2-3 
weeks in culture, neurons still exhibit morphological as well as electrophysiological properties 
similar to what has found in slices of the same age; in culture, synaptic reorganization, sprouting 
or selection of cells by death of certain cell types may occur.  
Without the lengthy process of coverslip cleaning, the use of chicken plasma clot or the 
slow rotation, interface preparation beats roller tube technique for simplicity. It only needs insert 
membranes and an incubator for culture. In the presence of plasma clot, studying events 
occurring during the first days in culture such as synaptic reorganization is difficult. In contrast, 
such studies are facilitated on slice cultures grown in membrane culture method, since an insert 
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membrane is transparent and has no autofluorescence. Cultures prepared from the membrane 
culture method flatten considerably during the first week but still maintain the thickness of a few 
cell layers, while those from the roller tube technique shrink to a monolayer thick over a great 
area. With increase in culturing time, the plasma clot that surrounds the tissue is progressively 
lysed away, leaving monolayer thick tissue directly on the coverslip. This monolayer 
characteristic obviously favors the visualization and accessibility of individual living cells. 
Tissues cultured by f ilter membrane technique show reduced gliosis in comparison to those 
cultured by roller tube technique, suggesting the long term culture brain tissues may fare better 
on membrane. 
Both methods have been utilized to culture and co-culture tissues derived from various 
regions of postnatal rat brains. Lack of extensive application suggests the difficulties of culturing 
slices from adult rat brain even though some researchers have made many efforts to improve the 
survival. Nevertheless, researchers36 have found the possible application of slice cultures from 
adult rat brain in the studies of age related neuronal degeneration and testing of neuroprotective 
compounds. They found that the cell death in the adult slice culture (specifically OHSCs) is 
time-dependent and reproducible. 
We chose interface preparation of OHSC in this research. OHSC has been used as a 
model to study neuroprotection against all sorts of neuronal cell damage induced by excitotoxins 
such as NMDA and kainic acid and by oxygen-glucose deprivation caused ischemia. It also has 
applications in studies of synaptic plasticity and neurogenesis. 
Hippocampus plays an important role in long-term memory and learning. Hippocampus 
is also highly susceptible to seizure and vulnerable to the effect of ischemia and anoxia. After a 
couple of weeks of culturing, OHSCs mimic many aspects of their in vivo counterparts. The local 
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synaptic contacts are still functional and the structure of hippocampus is well preserved. Each 
OHSC contains a laminar of the hippocampus structure.   
Compared to whole animal modes, slice culture based assay allows easier experimental 
access which is time-saving especially for studies involving screening of therapeutic molecules 
or novel genes. It also gives better control of the extracellular environment than is possible in 
vivo so that the biological outcomes can be simply elucidated, which is favorable for 
ectopeptidase activity studies. The thickness of an OHSC has been measured in our laboratory to 
be 148 ± 8 µm with an initial thickness of 400 µm after 6-8 days in culture37. Microdialysis or 
push-pull sampling is hard to apply to such a thin slice culture.  
1.2.2 The Feasibility of Sampling Based on Electroosmosis 
Cell membrane and extracellular matrix components include phospholipid head groups, proteins 
and sulfated carbohydrates. These components ionize in the presence of an electrolyte solution 
such as cerebrospinal fluid. The charges that originate from the cell surfaces and the immobile 
extracellular matrix affect the distribution of ions in the extracellular fluid (counter ions with an 
increased concentration close to the cell surface) and result in the development of an electrical 
double layer (Stern layer or compact layer and diffuse layer). Ions in the Stern layer are strongly 
bound to the cell surface while those in the diffuse layer are less firmly attached.  The ζ-potential 
is the electric potential at the slip plane between the mobile and stationary ions. The ζ-potential 
of an OHSC has been measured in our laboratory to be -22 mV38. 
Electroosmotic flow is the motion of liquid induced by an external electric field applied 
to a porous material, capillary tube, membrane or any other fluid conduit with fixed charges on 
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the surface and a moving electrolyte solution adjacent to it. The magnitude of electroosmotic 
flow depends linearly on the magnitude of ζ-potential as expressed in Equation (1) 
𝑣𝑒𝑜 = −(𝜀𝜁/𝜂)𝐸                 (1) 
where ε is the permittivity and η is the viscosity of the medium. An OHSC has a ζ-potential of -
22 mV, suggesting that electroosmotic flow containing extracellular solutes will be generated in 
the extracellular space once an electric field is applied.  
For a ch arged species, vobs is not equal to veo. It is  the sum of electroosmotic and 
electrophoretic velocity. The latter is defined in Equation (2). 
𝑣𝑒𝑝 = (𝜀𝜁𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒/𝜂)𝐸            (2) 
Where ζparticle is the ζ-potential defined by the surface charge on the particle. Thus, the observed 
velocity of a charged species can be expressed in Equation (3). 
𝑣𝑜𝑏𝑠 = 𝑣𝑒𝑜 + 𝑣𝑒𝑝 = −�𝜀𝜁𝜂 � 𝐸 + �𝜀𝜁𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝜂 � 𝐸             (3) 
When the two velocities are in opposite directions and of the same magnitude, the species does 
not flow. This will be the case for us when the sampled species is negatively charged. In other 
words, electroosmotic sampling may not be feasible for negatively charged species with a high 
electrophoretic mobility.  
1.2.3 Enkephalins and Their Degrading Enzymes 
We picked enkephalin degradation as the experiment probe because the separation of hydrolysis 
products of enkephalin is well established in our lab. The enkephalinases are localized in some 
9 
 
brain regions including the hippocampus. And many literatures are available on these pepitdases 
and their inhibitors, although most of the work has been done by slice homogenization or whole 
slice incubation experiment.  
Endogenous opiate system has been considered to be involved in a remarkable number of 
biofunctions. Enkephalins (Tyr-Gly-Gly-Phe-Met and Tyr-Gly-Gly-Phe-Leu), the first isolated 
endogenous opioid peptides, together with endorphins, dynorphins and orphanin compose the 
family of pain killing opioid peptides.  
It is believed that enkephalins are involved in a number of physiological functions, such 
as pain perception and analgesia, regulating emotions, responding to stress and ethanol exposure, 
and modulating social behavior39-43.  
Enkephalins are mainly degraded by ectopeptidases42-48. In the central nervous system 
(CNS), there are several peptidases acting upon enkephalins at various amide sites. Most of these 
peptidases are not located right at the enkephalinergic synapses where enkephlins are released. 
Therefore, the inactivation of enkephalins occurs in the extracellular space. There are about 
seven ectopeptidases showing activity of enkephalin hydrolysis44.   
Aminopeptidase N (APN) hydrolyses enkephalin by r emoving the N-terminal tyrosine. 
Immunohistochemistry results clearly indicate that this peptidase activity is primarily localized 
in blood vessels45. APN is distributed throughout the cerebral cortex, enriched in the caudate and 
moderately expressed in the hippocampus. Bestatin at 15 µM inhibits greater than 90% of this 
aminopeptidase activity. APN is less sensitive to puromycin. Puromycin at 25 µM inhibits less 
than 20 % of the enzyme activity42. Blood vessels associated APN is likely to contribute most of 
the enkephalin hydrolysis activity found in brain homogenates46. 
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Puromycin-senstive aminopeptidase (PSA), a ubiquitous enzyme, splits YGGFL at the 
Tyr-Gly peptide bond. Its concentration is the highest in the brain. Eighty percent of PSA present 
in cytosol and the rest is associated with membranes. But those membrane-bound PSAs mainly 
have their active sites facing intracellularly. Therefore PSAs are unlikely to function as 
ectopeptides. 
Neural aminopeptidase (NAP), a neuronal specific peptidase, was detected in rats only in 
the brain, spinal cord and olfactory bulb, but not in peripheral tissues44. It also has heterogeneous 
distribution in the CNS with the highest activity in the hippocampus and lowest in the olfactory 
bulb. It is only 28% as active as PSA in hippocampus (which accounts for 59% of the total brain 
aminopeptidase activity) and only 14% as active as P SA in the olfactory bulb. Eighty five 
percent of this neural specific peptidase is soluble and the rest is membrane associated. This 
peptidase is absent in glioma C6 and neuroblastoma SK-N-SH cells which indicates that the 
enzyme is unique to the CNS neurons. NAP is susceptible to aminopeptidase inhibitors including 
actinonin, arphamenine B, probestatin, and H-borePheC6H12. It is most sensitive to amastatin 
with a Ki of 0.04 µM, followed by bestatin (0.19 µM), proctolin (0.76 µM), puromycin (0.95 µM) 
and Arg0-enkephalin (4.75 µM). NAP is insensitive to the specific inhibitors of endopeptidase 
24.11 (thiorphan), angiotensin (II) convertase (captopril) and carboxypeptidase (GEMSA), which 
is similar to PSA.   
Neuron-specific aminopeptidase type 2 (NAP2) is similar to NAP. The majority (85%) of 
the activity of this neuronal aminopeptidase is found in cytosol and the rest is in the membranes46. 
It is also expressed exclusively in the CNS. NAP2 is most sensitive to amastatin with an IC50 of 
0.05 uM. NAP2, NAP and PSA are also equally susceptible to bestatin (IC50 0.2 µM) and 
proctolin (IC50 0.8 µM). Puromycin works upon all three of these peptidases with a different IC50. 
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NAP2 has regional activity distribution, more in the cerebral cortex than in the hippocampus, 
while NAP shows the highest activity in the hippocampus.  
Angiotensin-converting enzyme (ACE) releases YGG from enkephalin. ACE has very 
low activity in three different cell cultures including neurons, astroblasts and astrocytes since its 
specific inhibitor, captopril, has little effect on the cleavage at Gly-Phe peptide bond48. ACE is 
mainly expressed in endothelial cells, which may be present in the primary cultures.  
Dipeptidyl aminopeptidase (DAP) splits enkephalin to produce Tyr-Gly dipeptide. Its 
activity is much higher in neuronal than in the glial cultures. In the presence of bestatin, an 
inhibitor for aminopeptidase to prevent the degradation at Tyr-Gly position, Tyr-Gly becomes 
the main fragment in neuronal cultures, while Tyr-Gly-Gly is the main fragment in glial cultures. 
This aminopeptidase is present mainly in cytosol and its membrane bound activity is fairly low. 
Researchers even suspected that membrane-bound activity detected in experiments could be due 
to an intracellular enzyme which adsorbed to the cell membrane and leaked into the medium48. 
GEMSA is a sp ecific inhibitor for carboxypeptidase which has very low activity (not 
even detectable) on bo th neuronal cells and glials cell as demonstrated48. Carboxypeptidase 
hydrolyzes Met-enkephalin at Phe-Met bond. 
N4TG1 neuroblastoma cells, human endothelial cells, neuronal cells and astroblast cells 
from rat brains all have been demonstrated to hydrolyze enkephalins, mainly releasing the N-
terminal Tyr. Therefore, aminopeptidases, splitting enkephalins at such a specific bond, a re 
essential for the inactivation of enkephalin. A technique with improved spatial resolution and 
without perturbation from cytosolic enzymes or enzymes with active sites facing intracellularly 
will certainly help to clarify which peptidase is the most important for extracellular hydrolysis of 
enkephalin.  
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1.2.4 HPLC-EC System 
HPLC is an essential separation approach for peptides. For biological samples with a total 
available volume of only a few microliters, suitable HPLC conditions can be achieved by 
reducing column diameter and the diameter of packing particles of the stationary phase which 
greatly shortens the distance from the bulk of the mobile phase to stationary phase surface. As 
the packing particle diameter decreases, both the A term and the C term in the van Deemter 
equation decease, but back pressure at constant velocity increases. The simultaneous application 
of columns packed by small particles and higher flow rates are enabled by high pressure pumps. 
Sub-2 µm packing particles with good thermal stability are commercially available. Smaller 
particle size combined with high flow rate and high temperature speeds up the HPLC analysis. 
High temperature decreases the viscosity of the mobile phase and accelerates mass transfer, both 
of which speed up HPLC separation.  
HPLC can be coupled with antibody based binding assay, UV spectrophotometer, 
fluorescence, mass spectroscopy and electrochemical detection to complete the analysis of 
peptides. In this research, we chose electrochemical detection. Peptides with electroactive 
functional groups, W(Trp) and Y(Tyr), can be directly detected by an electrochemical detector. 
For those electrochemically silent peptides, the biuret reaction is used to convert them to 
electroactive derivatives49. Peptides longer than dipeptides react with Cu(II) to yield Cu(II)-
peptide complexes which can be electrochemically oxidized to the corresponding Cu(III) 
complexes. This reaction is reversible. A downstream cathode can be used to detect Cu (III) 
complexes to improve the selectivity. This electrochemical detection coupled with biuret reaction 
gives a detection limit as low as a few nM. Under certain conditions and with peptide 
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concentration less than 1 µM, the HPLC-EC system gives baseline resolution for the peptide 
peak. Peak areas and peak heights are proportional to concentrations. 
The derivatization process can be carried out pre-column or post-column50. There are 
some disadvantages of pre-column reaction. The reaction product has to be stable through the 
separation and detection process. The reaction might change the retention of the original forms 
of solutes so that the published separation procedure may not be directly adopted. Post-column 
reaction has its own problems. It requires additional hardware and reagents. It adds extra band 
broadening due to mixing following the separation. The band spreading issue has been addressed 
theoretically51 as well as experimentally52, 53. We used a mixer, in conjunction with a fused silica 
capillary Taylor reactor (CTR) (a simple, open tube long enough to permit diffusional relaxation 
of radial concentration gradients), as a post-column reactor. The CTR has been demonstrated to 
have negligible effect on the separation of a capillary column at optimal conditions. Thus, it is 
well-suited to mix reagents with effluent from a capillary column. 
We have demonstrated electroomostic sampling as a n ovel technique very suitable to 
extract extracellular fluid through a thin slice culture, which enables parallel experiments without 
sacrificing large numbers of animals.  T he spatial resolution has been assessed to be several 
hundreds of micrometers according to the area that is damaged during sampling (under extreme 
conditions). The spatial resolution is dependent on the inside diameter of the capillary; therefore 
it may be further improved by using a sampling capillary with a pulled tip. By controlling 
sampling time and electrical field strength, the sample dilution can be avoided.  The temporal 
resolution might be highly improved when coupling electroosmotic sampling with other proper 
and sensitive detections, which will benefit the analysis of low-concentrated endogenous 
neuropeptides or neurotransmitters in specific brain areas. For instance, electroosmotic sampling 
14 
 
has been married with microfluidic chips and a co nfocal laser induced fluorescence (LIF) 
detector to successively sample, separate and detect the extracellular thiols in hippocampal tissue 
cultures54.   
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Chapter 2 Electroosmotic Sampling. Application to Determination of 
Ectopeptidase Activity in Organotypic Hippocampal Slice Cultures. 
This work has been published in Anal. Chem. 2010, 78, 1761-1768. 
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2.1 Introduction 
Neuropeptides play a key role in brain and peripheral nervous system functions such as pain and 
learning1. They are mainly inactivated by e ctopeptidases – outward-facing, membrane-bound 
peptidases that cleave the active peptides into inactive fragments2-4. Extracellular peptidases 
create active forms of BDNF5, substance P6, cholecystokinins4 and alter the activity of 
dynorphins7. Recent work shows that peptidases are important in the degradation of amyloid8, 9. 
Also, attenuated peptidase activity following stroke can contribute to neurotoxicity and an 
endogenous blocker of the ectopeptidase that cleaves enkephalin has powerful analgesic 
effects10. Thus, a deeper understanding of peptidase activity is necessary for understanding both 
normal and pathological brain function, as well as for the development of novel strategies for 
drug development. 
While the central focus of this paper is electroosmotic sampling, the determination of 
peptidase activity in tissue is an important direction. Peptidase activity has been a concern in 
microdialysis experiments. Microdialysis sampling of peptides is improved in the presence of 
peptidase inhibitors11-17. Recently, the Stenken group18, 19 has developed microdialysis 
approaches to in vitro (enzyme solutions) determination of protease activity. In vitro (slice) 
studies of peptidase inhibitors lead to knowledge of the peptidases active in a whole slice15, 20. 
Finally, several research groups have analyzed peptidase activity (dynorphin A21, 22, substance 
P23, endorphin24, and peptide E25) in vivo with microdialysis. Most of our understanding of 
peptidases has come from analysis of tissue extracts, homogenate or fraction by determination of 
peptide fragments by H PLC26, 27 or by s tandard enzyme methods (fluorogenic substrate)28, 29. 
More modern methods are demonstrating more chemically detailed information at the organism 
level. For example, high resolution separations followed by mass spectrometry have been used to 
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investigate a knockout mouse missing the gene producing dipeptidyl peptidase 4 a llowing the 
discovery of the influence of that enzyme on the peptidome30, 31. In another example, mass 
spectrometry was applied to the analysis of the differential peptidome in rat striatum resulting 
from K+-induced depolarization32. The approaches illustrated open the possibility of asking and 
answering more refined questions about peptides and peptidases, including localized 
measurements in tissue, in vivo and in vitro. One pragmatic issue concerning analysis of 
ectopeptidase activity is that any tissue fractionation will release intracellular peptidases that will 
contribute to peptide breakdown. It follows that it is preferable to perform analysis of 
ectopeptidase activity with intact cells or tissues when possible.  
The organotypic culture method provides a route to in vitro models of in vivo tissue. 
Stoppini and co-workers described a simple preparation technique for hippocampal organotypic 
cultures33. The hippocampus is a brain area responsible for some forms of memory and learning, 
and is highly susceptible to damage from seizures, ischemia and anoxia34. Cultured hippocampal 
tissue survives for several weeks. The local synaptic circuitries are still functional and the 
structure of the hippocampus is well preserved35. In a wide spectrum of studies, the organotypic 
hippocampal slice culture (OHSC) has been established as a reliable model2, 36. For our purposes, 
OHSC-based assays allow for better control of the extracellular environment than is possible in 
vivo. Thus, for studying ectopeptidases, a medium free of soluble peptidases can be used3. 
Neuropeptide hydrolysis in the extracellular space in slice cultures has been reported37 using the 
classical sampling approach in which tissue is incubated in a solution containing substrate, and 
products are detected in the medium after some time. Although this gives a measure of the 
endopeptidase activity in the entire slice, ectoenzyme activity in subregions of a specific brain 
area such as the hippocampus is not possible with this approach. 
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We propose a novel sampling method based on electroosmosis and apply it to OHSCs. 
The ζ-potential of OHSCs has been measured in our laboratory38. The ζ -potential is the potential 
of an object along a sh ear plane that separates fixed charges on the object and a moving 
electrolyte solution adjacent to it. In the OHSC, the fixed charges originate from charges on cells 
and the extracellular matrix. Application of an electric field to a porous medium like the OHSC 
with fixed charges creates an electroosmotic (EO) flow of the electrolyte. EO flow is the bulk 
fluid flow derived from the force of the electric field on mobile counterions that reside near the 
fixed charges. The magnitude of EO flow depends linearly and independently on the magnitudes 
of ζ-potential and the externally applied electric field.  The OHSC’s ζ-potential is -20 - -25 mV 
suggesting that when an electric field is applied to the tissue, an electroosmotic flow containing 
extracellular solutes will be generated in the extracellular space. In this work, we demonstrate the 
feasibility of this novel electroosmotic sampling approach for extracelluar fluid extraction. We 
have applied this method to the determination of ectopeptidase activity on Leu-enkephalin in the 
CA3 region of rat OHSCs with HPLC-EC.  
2.2 Experimental Section 
2.2.1 Solutions.  
All chemicals used in the preparation of OHSCs were purchased from Sigma (St. Louis, MO). 
All aqueous solutions were prepared with purified water from a Millipore Synthesis A10 system 
(Millipore Corporation, Billerica, MA). Gey’s balance salt solution (GBSS) was fortified with 
2.7 mM MgSO4 and 0.45 %  D-(+)-glucose. Culture medium consisted of 50% basal medium 
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Eagle, 25% Earle’s balanced salt solution, 23% horse serum, 25 U/mL penicillin streptomycin 
solution, 1 mM L-glutamine and 7.5 g/L D-(+)-glucose. Hepes buffered salt solution (HBSS) 
was composed of (mM): 143.4 NaCl, 5.0 HEPES, 5.4 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 2.0 CaCl2, 
and 10 D-(+)-glucose. The pH was adjusted to 7.40 with 0.5 M NaOH before filtering (0.45 µm 
PTFE). HBSS was kept frozen until use. 
Peptides, inhibitors and sources were as follows: YGGFL, GGFL, GGFM and thiorphan 
(Bachem Americas, Inc, Torrance, CA); 2-Guanidinoethylthio succinic acid (GEMSA), 
puromycin, captopril and bestatin (Sigma, St. Louis, MO); DYDAGDFDL was synthesized by 
Biomedical Research Support Facilities (BRSF) of University of Pittsburgh. All solutions were 
prepared in HBSS solution. 
2.2.2 Preparation of OHSCs.   
The procedures described here have been approved by t he IACUC of the University of 
Pittsburgh. The preparation of OHSCs is slightly modified from the Stoppini culturing method33. 
After rats (7 days postnatal) were decapitated, the hippocampal area was removed and chopped 
into 400 µm slices by a McIIwain tissue chopper (The Mickle Laboratory Engineering Co. Ltd, 
UK). Slices were placed in ice-cold GBSS solution using a d issecting microscope (Fisher 
Scientific, Pittsburgh, PA), the individual slices were then transferred onto membrane inserts (0.4 
µm-pore size culture plate insert, Millipore Corporation, Billerica, MA) in a 6-well plate 
(Millipore Corporation, Billerica, MA), The slices were cultured over culture medium in a 
humidified incubator (Thermo Electron Corporation, Asheville, NC) at 37 ºC with 5% CO2/air. 
Medium was exchanged every three days. Slices were normally cultured for 6 to 8 days. Before 
use, medium was removed from the dishes and replaced with GBSS (refrigerated till use and 
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warm up to 37 ºC), incubated (37 ºC) for 30 minutes, the previous step was repeated, and then 
the OHSCs were kept in HBSS (37 ºC). 
2.2.3 Cell Death Determination    
An inverted fluorescent microscope (Olympus IX71) with an Olympus Plan Apo 1.25× objective 
lens (both from Olympus, Melville, NY) was employed to image the OHSCs using a CCD 
camera (ORCA-285 IEEE 1394 -Based Digital Camera, Hamamatsu Photonics K.K., Japan). A 
Semrock (Rochester, NY) DA/Fl/TA-3X-A Triple-band ‘‘Pinkel’’ filter set (exciter I, 387 nm; 
exciter II, 494 nm; exciter III, 575 nm; dichromatic mirror: 394–414 nm, 484–504 nm, 566–586 
nm; emitter: 457, 530, 628 nm) was used for imaging of propidium iodide (PI)-stained OHSCs. 
Details of this procedure can be found in the companion paper39. Briefly, following a sampling 
experiment, OHSCs were provided with fresh medium containing PI (final concentration is about 
12 µM). After 16 t o 24 hours, images were taken for % death measurement. The % death 
measurement is based on the fluorescence intensity of the PI in the sampled area. One hundred% 
death represents PI fluorescence from an OHSC killed by exposure to liquid methanol until 
opaque; 0% control OHSCs were handled (medium exchange, moved from incubator to lab and 
back) as experimental OHSCs, but were not sampled (Equation 1). % 𝑑𝑒𝑎𝑡ℎ =  (𝑀𝐼𝑠 − 𝑀𝐼𝑐)/(𝑀𝐼𝑘 − 𝑀𝐼𝑐)      (1)  
where MI represents mean fluorescence intensity of PI, s is the sampled OHSC, c is the 0% 
control OHSC, and k is the 100% dead OHSC.  
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2.2.4 Electroosmotic Sampling Set-up.  
 In the sampling set-up as displayed in Figure 2.1, we had:  a ) two Petri dishes containing the 
same volume of solution to avoid siphoning; b) an insert membrane to hold the OHSC; c) a 
sampling capillary with one tip positioned near the tissue surface and the other one dipped into 
buffer solution in the other dish; and d) two Pt electrodes connected to a power supply to 
complete the electric circuit. An electronic micromanipulator (Model TSX-1, Sutter Instrument 
Company, Novato, CA) was used to position the capillary tip. Once an electric field is applied, 
fluid is drawn into the sampling capillary by electroosmotic flow. Samples were ejected from the 
capillary using a 50 µL syringe containing 40 µL (sometimes 20 µL) 0.1% TFA. This represents 
approximately a 100 (50)-fold dilution. A further 2 – 37.5-fold dilution depending on t he 
concentration of peptide in the bath was made before injection into an HPLC-EC system for 
analysis. A 150 µm ID × 30 cm (length) capillary was used in all experiments unless described 
otherwise. 
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Figure 2.1 The set-up for electroosmotic sampling. A. a picture of the left side of the set-up  B. a 
bright field image of an OHSC  C. a schematic figure of the set-up. 
2.2.5 HPLC-EC System.  
We utilized a Waters 600 E quaternary pump (Waters Corporation, MA) to deliver the mobile 
phase (23% acetonitrile, 3% 1-propanol, 0.1% trifluoroacetic acid and Milli-Q water) at 100 
µL/min and a simple tee to split the flow. After splitting, the mobile phase flowed through a 
VICI injector (Valco Instruments Co., Houston, TX) and then a 75 µm ID capillary column at 
about 1 µL/min. The 9-cm long column was packed with 2.6 µm C18 particles in the laboratory 
as described by K ennedy et al40. Peptides were detected electrochemically following a 
postcolumn reaction. The effluent from the column was mixed with biuret reagent (0.24 M 
carbonate buffer, 12.0 m M disodium tartrate and 2.0 m M copper sulfate, pH 9.83) to form 
electrochemically active complexes which were detected at a 10 µm carbon fiber electrode at an 
applied potential of  + 0.55 V versus Ag/AgCl.  P otential was controlled with a BAS Epsilon 
potentiostat (W. Lafayette, IN). Biuret reagent was delivered by an Isco model DM syringe 
pump (Harvard Apparatus, Holliston, MA) at 0.3 µl/min. The post column derivatization was 
performed in a Capillary Taylor Reactor (CTR)41 with an inner diameter of 75 µm. The HPLC-
EC system was depicted by Xu et al.42. Under the specified conditions and with peptide 
concentrations less than 1 µM, this system gives baseline resolution for the peaks of interest. 
Peak height and peak area (PeakFit Version 4, AISN Software, Inc.) are proportional to 
concentration.  Because we pack columns locally and we use flow splitting, there is a variability 
of retention times. Thus, peptide standards are always used for peak assignments. 
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2.2.6 Observation of Electroosmotic Flow in Tissue.  
This experiment was carried out to create an image that would demonstrate the phenomenon – 
that the application of an electric field pulls solution through the tissue. Samples obtained from 
this experiment were not analyzed. An insert membrane supporting an OHSC was placed into a 
Petri dish (60 × 15 mm) containing approximately 3 mL of HBSS. A100 µm ID × 30 cm long 
fused-silica sampling capillary filled with HBSS was held orthogonal to and just touching the 
OHSC. The proximal end of the capillary was placed in a vial containing HBSS and a platinum 
wire (1 mm diameter). The vial was sealed and positioned to avoid siphoning. A gold minigrid 
electrode (~5 µm thick) was placed on t he bottom of the Petri dish, under the insert 
membrane/OHSC. The platinum wire and gold minigrid were connected to a high voltage power 
supply (Stanford Research Systems, model PS350, Sunnyvale, CA). A slit was cut into the side 
of the Petri dish, allowing for a 25 µm ID fused-silica injection capillary to be positioned under 
the insert membrane and above the gold minigrid. Capillaries were cut flat and clean using a 
Shortix capillary cutter with a diamond blade (Middelburg, Netherlands). The injection capillary 
was filled with 10 µM Thioglo-1 (Covalent Associates, St. Louis, MO) in HBSS. The tissue and 
minigrid were in the optical path of the IX-71 inverted fluorescence microscope and imaged 
using a U Plan Apo 4× objective lens (Olympus) and a specially-built Omega fluorescence cube 
(Omega, Brattleboro, VT): 378 n m excitation and 480 nm  emission. Simple PCI software 
acquired the images.  When the tissue is in place, image acquisition was initiated. In experiments 
(controls) three (zero) kV were applied to the system, followed by the injection of Thioglo-1 dye 
under the insert membrane. 
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2.3 Result and Discussion 
2.3.1Demonstration of Electroosmotic Sampling 
2.3.1.1 Proof of Principle.  
Initial proof of principle experiments were carried out by exposing tissue to a low concentration 
of a neutral, membrane permeant, thiol reactive, fluorogenic reagent, Thioglo-1. This reagent 
reacts with thiols in the cell, chiefly glutathione (GSH). Cells exposed to this reagent become 
fluorescent rapidly. In experiments, a blunt-ended, electrolyte-filled capillary was placed on the 
tissue. Contact with the tissue can be discerned while doing the capillary placement, however the 
image of the end of the capillary when it is in place is quite variable, as the image is taken 
through the minigrid, the support membrane, and the tissue. (See Figure 2.2: A1 and B1). A brief 
injection of the Thioglo-1-containing electrolyte under the insert membrane supporting the tissue 
leads to significant fluorescence under the capillary and in the capillary lumen in the experiment 
(B1-B3 in Figure 2.2). In the control where no electric field is applied, no change is observed in 
the image (A1-A3 in Figure 2.2). This demonstrates that application of an electric field through 
the OHSC and insert membrane into a fused-silica capillary creates an electroosmotic flow into 
the capillary lumen. Thus, the cells around the capillary opening fluoresce with Thioglo-1. 
Without the electric field, there is no change in the luminescence intensity near the sampling 
capillary.  
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Figure 2.2 Inverted fluorescence image (4× objective lens) of an OHSC, grown on an insert 
membrane, with a fused silica capillary positioned orthogonally, directly above the OHSC. A. 
No applied voltage at time 1) 0 s, 2) 6.6 s, and 3) 13.2 s. B. 3 kV applied, images taken at times 1) 
0 s, 2) 6.6 s, and 3) 13.2 s. The Thioglo-1 injection capillary is outside of the field of view of 
these capillaries. 
2.3.1.2 Peptide Sampling.   
YGGFL is a neutral neuroactive peptide. Its enzymatic hydrolysis was employed as a probe to 
evaluate electroosmotic sampling. We used DYDAGDFDL, an analog of YGGFL containing D 
amino acids, as an internal standard (IS). This peptide is resistant to enzymatic degradation43 .  
Solutions of the IS and YGGFL in HBSS comprise the medium during sampling. As described in 
the experimental section, an electrolyte-filled capillary is placed perpendicular to and near or 
touching the surface of an OHSC which is in contact with the medium through an insert 
membrane. When current flows from the medium beneath the OHSC into the capillary, 
electroosmotic flow will carry neutral molecules of similar size and shape into the capillary at 
about the same flow rate. Thus YGGFL and the IS will have very similar velocities since they 
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are both virtually neutral and they have similar molecular weights. The biuret complex of the IS 
also has a similar electrochemical response to the biuret complex of YGGFL.  Thus, if the 
concentrations of the two species are the same in the bath, the YGGFL peak will have a similar 
area to the IS peak if there is no enzymatic degradation.  
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Figure 2.3 Demonstration of electroosmotic sampling. Chromatograms of samples obtained by 5 
min electroosmotic sampling at an electric field of 46.7 V/cm with the capillary tip positioned on 
different surfaces: CA1 sub-region of an OHSC (bottom) and the surface of the same insert 
membrane adjacent to the OHSC (top). 150 µM YGGFL and DYDAGDFDL (IS) in HBSS buffer 
solution served as the solution under the insert membrane. The samples were mixed with 20 µL 
0.1% TFA for the former case and 40 µL 0.1% TFA for the latter. 
 
Figure 2.3 displays typical chromatograms of the samples obtained by electroosmotic 
sampling. GGFL elutes first, followed by YGGFL and then IS. When samples are drawn through 
the OHSC, some of YGGFL is hydrolyzed into GGFL. The sum of the YGGFL and GGFL 
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concentration is still smaller than that of the IS, implying the presence of other undetectable 
products. When the capillary tip was moved onto the insert membrane surface adjacent to the 
slice culture, the YGGFL peak is almost as large as the IS peak which means most of YGGFL 
remains intact during the sampling. Only a small GGFL peak is observed. The small GGFL peak 
results from the presence of cells in the membrane adjacent to the culture itself. The results 
clearly indicate that YGGFL has been carried through the slice culture and that it was hydrolyzed 
in the tissue. The result verifies the feasibility of this novel electroosmotic sampling method and 
implies its possible application in the enzymatic studies. 
2.3.2 Damage Caused by Electroosmotic Sampling.  
Figure 2.4 contains representative images of slice cultures taken before and after electroosmotic 
sampling compared with the image of a slice culture exposed to methanol. When the electrolyte-
filled capillary tip was positioned directly on the surface of the slice culture, some cell death 
appears around the sampling area 18-24 h after sampling (a red area shows up in A2 compared 
with A1, the image taken from the same slice culture before electroosmotic sampling) but the 
rest of slice looks normal. When the capillary tip was placed 50 µm away from the surface of the 
slice culture (with electrolyte connecting them), no obv ious damage occurs (no darker red is 
observed in B2 compared with B1). We report in more detail in a companion paper39 that % 
death is less than 10% when sampling in CA3 for 5 min at an electric field of 46.7 V/cm, with a 
capillary having an inner diameter less than or equal to 180 µm, and positioned 15 µm or more 
from the surface. 
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Figure 2.4 Images of OHSCs before (A1, B1) and after (A2, B2) 5 min sampling at an electric 
field of 46.7 V /cm with a 150 µ m (ID) × 30 cm capillary. The capillary tip was positioned 
directly on (A2) or 50 µm away from theOHSC surface (B2). Image C is taken from a controlled 
OHSC treated with MeOH. Image A1 and A2 were taken from the same OHSC, as were B1 and 
B2. 
 
The investigation of ectopeptidase activity should be immune to misinterpretation from 
damage. As membrane-bound proteins, their volume-average concentration does not change on 
the minutes timescale over which sampling occurs. They do not rely on metabolism to function. 
Indeed, most assays begin by hom ogenizing the tissue! Thus, our approach is quite gentle by 
comparison. This is not to say that the cell death and even the electric field itself may be 
unwanted in a particular experiment. Certainly, a level of caution must be used in applying any 
sampling procedure to live tissue. 
The ζ-potential of a OHSC has been measured to be about -22 mV in our laboratory38, 
while it is about -50 mV for a silica capillary after proper preconditioning. The mismatch in ζ-
  
A1 
C B1 B1 
A2 
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potential produces a pressure driven flow into the capillary which forces the slice surface against 
the capillary tip during electroosmotic sampling. This may contribute to the physical damage 
when the capillary is actually touching the tissue. Joule heating at the capillary tip might be 
another source of the damage. 
Table 2.1 The Possibility of Cytosolic Enzyme Release under Very Tough Conditions 
Runs 1 2 3 4 
Difference in conversion rates -5% 2% 2% -1% 
p-value of a student t- test = 0.39 
Electric field was 67.7 V/cm; capillary ID was 180 µm and the sampling time 
was extended to be 15 min. 
 
To see w hether the sampling process causes the release of cytosolic enzymes during 
electoosmotic sampling, we carried out the following experiments under conditions as given in 
Figure 2.4: samples were collected and split after sampling. One aliquot was mixed with 0.1% 
TFA (to stop enzyme activity) right after the sample was collected, whereas the other aliquot 
remained at room temperature for 45 min before 0.1% TFA was added. The conversion rates of 
GGFL from YGGFL, defined as [GGFL]/([GGFL]+[YGGFL]), were measured for both aliquots. 
The differences in conversion rates (shown in Table 2.1) were statistically zero (four repeats; % 
difference ranging from -5% to 2%, p = 0.38 for null hypothesis that there is no difference). Thus, 
YGGFL hydrolysis did not continue after the sample collection implying that no soluble 
cytosolic peptidases were extracted. Therefore, only the membrane-bound ectopeptidases 
hydrolyze YGGFL during electroosmotic sampling. This is an advantage in comparison to 
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procedures that homogenize tissue. Sampling the extracellular space excludes the influence from 
those membrane-bound enzymes having their active sites facing intracellularly. 
2.3.3 Measurement of Sampling Flow Rate 
2.3.3.1 Single IS Method.  
During electroosmotic sampling, existing extracellular fluid reaches the sampling capillary 
before solution from the bath that is drawn through the OHSC. It is  the latter solution that 
contains IS. Thus, the total sampled volume should be the sum of these two volumes as 
expressed below: 
BATHECFS VVV +=           (2) 
VECF and VBATH represent the sampled volume from the extracellular space and the bath solution, 
respectively. VBATH is obtained from sampled molIS (see equation 2 in Supporting Information) 
divided by the initial concentration of IS in the bath. VS, the total sampled volume, is 
proportional to the applied electric field. By rearranging Eq. 2, we obtained  
ECFECFSBATH VkEtVVV −=−=        (3) 
E is the applied electric field, t is the sampling time, and k is related to the ‘apparent’ ζ-potential 
(ζAPP) in the tissue by  
2)/( ak APP ⋅−= πηεζ          (4) 
 where a is capillary radius, ε is permittivity, and η is viscosity. We use ‘apparent’ ζ -potential to 
account for the ζ-potential mismatch between the capillary and the OHSC mentioned above. 
There will be a small contribution from pressure-induced flow adding to the electroosmotic flow. 
As we do not explicitly account for this in Eq. 4, we use an apparent ζ-potential. By plotting 
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VBATH against E, we obtained VECF from the y intercept as 205 ± 55 nL. The sampling flow rate 
can be calculated as VS divided by the sampling time. It ranges from 60 to 150 nL/min under the 
conditions applied. The apparent ζ- potential is about -29 mV slightly larger in magnitude than 
the measured ζ- potential of an OHSC, -22 ± 2  mV. The observed difference between the 
previously measured and the apparent ζ-potentials is consistent with the flow having a small 
pressure-induced component due to the larger (negative) ζ-potential in the capillary. 
It is interesting to note that the applied field controls where the sample comes from. The 
linear regression of VBATH on E (VBATH= 10.3 E (V/cm) – 205 nL) shows that a field of 20 V/cm 
will provide a VBATH of zero. Thus, fields below 20 V /cm provide extracellular fluid from the 
tissue under the conditions used, whereas fields greater than that will sample fluid from the bath 
below as well as the extracellular fluid. Consequently, conditions for obtaining the extracellular 
fluid, and thus capturing endogenous species, are easily attained. 
2.3.3.2 Two IS Method.  
 In many experiments, an average flow rate based on the data just discussed may be sufficient. 
However, it would be beneficial in some circumstances to have an indication of the flow rate for 
each run. GGFM, used as a second internal standard, is filled in the sampling capillary. When 
sampling starts, GGFM solution is gradually replaced by extracellular fluid and then by ba th 
solution. Thus, the sampling capillary is filled with GGFM solution, extracellular fluid and bath 
solution in the end if the sampling time is not too long. Eq. 5 expressed the volume distribution 
in the capillary. 
𝑉𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 =  𝑉𝐺𝐺𝐹𝑀 + 𝑉𝐸𝐶𝐹 + 𝑉𝐵𝐴𝑇𝐻 = 𝑉𝐺𝐺𝐹𝑀 + 𝑉𝑆      (5) 
In every run of sampling, both VGGFM and VBATH can be indirectly obtained from the 
chromatograms. Vcapillary is determined based on a chromatogram from the capillary filled with 
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GGFM solution only. VS and VECF can be calculated according to Eq. 5. Thus, the two IS method 
allows a direct determination of sampling flow rate in every run. The average sampling flow rate, 
112 ± 43 ( s.d.) nL/min at an electric field of 50 V/cm, is indistinguishable from103 nL/min, 
obtained from the single IS method under the same conditions. The large standard deviation 
confirms the need for this two IS method. The sampling flow rate is easily adjusted by t he 
applied electric field and the diameter of the capillary. 
2.3.4 Sampling Bias.   
The observed mobility of a molecule in the extracellular space is the sum of its electroosmotic 
mobility and its electrophoretic mobility. For a negatively charged species whose electrophoretic 
mobility opposes its electroosmotic mobility, sampling could be a problem. According to Eq.6, 
𝑢𝑂𝐵𝑆 = 𝑢𝐶𝐸 + 𝑢𝐸𝑂 = 𝑧6πηr + 𝜀ζ𝜂         (6) 
where uOBS, uCE and uEO represent the observed mobility, electrophoretic mobility and 
electroosmotic mobility, respectively. z is the net charge of the molecule, η is viscosity, r is the 
Stokes radius, ε is permittivity and ζ is zeta potential. For a low-molecular-weight species with a 
negative charge of - 0.6, the solute’s velocity is 0 a s the electroosmotic and electrophoretic 
mobilities are equal and opposite. In practice, however, the pressure-driven flow generated by 
the ζ-potential mismatch works to minimize this problem. For example, fluorescein which is 
practically a dianion at physiological pH, can be sampled electroosmotically.  
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2.3.5 Indentifying the Peptidase Pharmacologically by Electroosmotic Sampling. 
 There are several peptidases that may act upon Leu-enkephalin in rat brain. The 
aminopeptidases (aminopeptidase N (APN), puromycin- sensitive aminopeptidase (PSA) and 
two neuron specific aminopeptidases (NAP and NAP2)) cleave the N-terminal tyrosine from 
enkephalins. Other enzymes include carboxypeptidase, angiotensin-converting enzyme (ACE), 
dipeptidyl aminopeptidase (DAP) and enkephalinase (NEP), which hydrolyze YGGFL at other 
amide bonds. This aminopeptidases can be separated into two categories: bestatin-sensitive 
aminopeptidase (APN) and puromycin-sensitive aminopeptidase (PSA, NAP and NAP2).  
Puromycin-sensitive aminopeptidases are effectively inhibited at 20 µM puromycin44-46. 
Carboxypeptidases cleave YGGFL at the Phe-Leu amide bond with a Km in the mM range47. This 
enzyme is specifically inhibited by G EMSA. DAP cleaves YGGFL into YG and GFL. This 
peptidase is primarily located in the cytosol - its membrane activity is low48. NEP and ACE 
cleave YGGFL to produce YGG and FL49.  T hiorphan is a selective inhibitor for NEP while 
captopril inhibits ACE.  B ased on t his information, we used puromycin, thiorphan, GEMSA, 
captopril, and bestatin to selectively block particular classes of peptidases in order to determine 
which peptidase is the most important in YGGFL hydrolysis in OHSCs. Typical chromatograms 
are displayed in Figure 2-5. Note that high concentrations of YGGFL were used because of the 
high Km values anticpated. An approximately 200 – 3700-fold dilution of the sample preceded 
analysis to keep the injected concentration less than 1 µM (see experimental section).  
GGFM elutes at about 10.5 min, followed by GGFL, YGGFL and IS. Four experiments 
were performed under conditions described in Figure 2.5. A one-way analysis of variance of the 
enzyme rate based on either GGFL production or YGGFL loss (see SI for the derivation of 
enzyme rate) shows that a significant difference exists among experiments A, B, C, and D. 
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However, there is no significant difference among experiments A, B, and C. Thus, bestatin is the 
most effective inhibitor. We conclude that a bestatin-sensitive aminopeptidase may contribute in 
the inactivation of exogenous YGGFL in the extracellular space in the CA3 region of the 
hippocampus. 
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Figure 2.5 Five min sampling through CA3 at 50 V/cm. The bath solution is HBSS with 150 µM 
YGGFL and IS with or without inhibitors as follows: Experiment A, no inhibitors; B, includes 
inhibitors (µM) of thiorphan (15), GEMSA (210), captopril (25). C, As B plus puromycin (20). 
D, as C plus bestatin (100). 
 
The degradation paths of YGGFL depend on the tissue being studied and the method of 
measuring enzyme activity. The cleavage of the Tyr-Gly amide bond represents the only 
detectable inactivation pathway in homogenates or soluble fractions of brain tissue, while 
cleavage of the Gly-Phe bond r epresents about 20% with particulate fractions50 and may even 
reach 65% with synaptosomes51. In our observations in the OHSC, 72% of YGGFL hydrolysis 
38 
 
occurs at Tyr-Gly. The hydrolysis at Tyr-Gly of exogenous YGGFM in rat striatal slices is about 
80% of the total hydrolysis37, which is similar to our result. In this experiment, YGGFM diffuses 
into the entire extracellular space and reacts with the ectoenzymes. There is a considerable 
variation in enkephalin-degrading activity across the human brain52. This emphasizes the 
necessity of spatial resolution, something that the current approach can provide. 
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Figure 2.6 Substrate saturation curve for ectoaminopeptidase-catalyzed YGGFL hydrolysis. All 
bath contains 15 µM thiorphan, 210 µM GEMSA, 25 µM captopril and 20 µM puromycin. 
 
Finally, we challenged OHSCs with different concentrations of YGGFL to determine a 
value of Km. The initial velocity is defined as [GGFL]/te, where te is the exposure time of 
YGGFL in the OHSC (see Supplemental Information for details of te derivation) te is calculated 
to be 1.5 s under the conditions used. This calculation involves the assumption that the sampled 
volume is a cylinder in the tissue with the same diameter as the inside diameter of the sampling 
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capillary, which is probably an underestimate. The initial velocity is plotted (Figure 2.6) as a 
function of [YGGFL], the initial concentration of the substrate. The YGGFL hydrolysis 
displayed a typical Michaelis-Menten behavior. We obtained Vmax and Km as 770 ± 95 µM/s and 
1.2 ± 0.5 m M, respectively. This Km value is similar to published values. While endogenous 
peptide concentrations tend to be low, peptidase Km values are rather high. The high Km values 
are consistent with the modest selectivity that is typical of peptidases. 
Electroosmotic sampling appears to be effective. We have not determined the spatial 
resolution here quantitatively, however it is well known that the electric field, and thus 
electroosmotic velocity, decreases steeply as a function of distance from the tip. Of course, the 
electroosmotic velocity also depends on the applied field. We estimate, based on the images of 
tissue damage (when it occurs) that the spatial resolution is on t he order of several hundred 
micrometers. This will need to be established more rigorously in the future. This distance 
dependence is proportional to the inside diameter of the capillary While there are complexities 
caused by t he inhomogeneous electric field in the tissue, the overall approach is simple and 
ideally suited to slices or sampling from the surface of an organ, for example. In vivo 
application can be envisioned with narrower or pulled capillaries. Peptidase chemistry, e.g., 
selectivity, is very well understood (see http://merops.sanger.ac.uk/). However, ectopeptidase 
activity in intact tissue with spatial resolution is not. Imaging approaches based on fluorescence-
generating substrates can provide more detailed information, even at the single-cell level, about 
the presence of peptidases53-55. For answering questions about native substrate metabolism, its 
space- and time-dependence, analysis of the native peptide substrate and its hydrolysis products 
is essential. The ability to measure peptidase activity with chemical and spatial selectivity 
should improve our understanding of how this important class of enzymes controls extracellular 
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peptide activity. Electoosmotic sampling could find its application as well in extracellular 
endogenous peptide extraction and determination when combined with appropriate quantitative 
analytical approaches. An important question is the relationship between the extracellular 
concentration and the concentration in the sampled fluid. While this remains to be determined, 
we have good reason to believe that calibration in a suitable matrix, e.g., sampling from a well-
characterized hydrogel with a known ζ-potential, will be possible. 
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Chapter 3. Optimization of Postcolumn Reactor Radius in Capillary High 
Performance Liquid Chromatography. Effect of Chromatographic Column 
Diameter and Particle Diameter. 
This work has been published on J. Chromatogr. A 2006, 1113, 116-22. 
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3.1 Introduction 
It is well-known that post-column reactions can improve sensitivity and selectivity in liquid 
chromatographic analysis1-3. In just the past couple of years, papers using postcolumn reactions 
for a variety of bioanalytical applications have appeared, including amino acids and peptides4,5, 
for fatty acid hydroperoxides in MEKC6, for japonicus/polysaccharide7, for glucosylated 
flavonoids8, for acetyl-CoA esters9, for phosphorylated peptides10, for drugs (competitive 
binding)11, for glucose and insulin12, for bradykinin13, for drugs14, for lipoproteins15, for 
tocopherols16, for phosphorylated sugars17, for peptides3, 18-21. One should include the preparation 
of MALDI plates as a p ost-column reaction22. Recent applications in environmental chemistry 
using postcolumn reactors include glyphosate23, iodate and bromate24, thiourea25, anions26, and 
ion chromatography27. However, post-column reactors come with some disadvantages. The most 
obvious are the additional hardware and reagents required, and the band spreading associated 
with the additional mixing following the separation.  
The band spreading issue, as i t is treatable theoretically, has been addressed. Huber, 
Jonker, and Poppe28 considered the problem of using rather slow chemical reactions following 
the separation. They concluded that a packed bed reactor was superior to an open tubular reactor. 
In their work they assumed that mixing, as opposed to reaction, was instantaneous. On the other 
hand, Kucera and Umagat29 considered the case of post-column reactors for microbore columns. 
With smaller peak volumes than in 4.6 mm ID (inside diameter) columns, microbore columns 
pose more of a challenge for post-column reactor design. These workers considered a f ast 
reaction, o-phthalaldehyde with amino acids and primary aliphatic amines. They proposed a 
simple tubular reactor. Special attention was paid to creating a low-volume mixing ‘tee’. Peak 
variances depended linearly on the square of the reactor diameter, showing that the 
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chromatography was compromised. In other words, they did not employ a reactor diameter small 
enough to make the additional band spreading from the reactor negligible. With 50 cm x 1 mm 
columns operating at 35 µL per minute, and with an equivalent post-column reagent flow rate, 
they used postcolumn reactor tubing in the 180 to 250 µm ID range.   
Other workers have optimized postcolumn reactors experimentally. The sheath-flow 
approach has proven suitable for CE of DNA30.  O ptimization of postcolumn conditions for 
chemiluminescence detection has been achieved31.  Hollow fiber membrane systems have been 
optimized to minimize band spreading32.  The virtue of inducing secondary flow for improving 
radial mixing has been shown by Selovaka et al.33.  C ontributions to band spreading were 
evaluated in a postcolumn reactor for photochemical reactions34 and for saccharides35. Much of 
this work is dated, and applies to columns with typical dimensions of 4.6 mm ID, 10-20 cm long 
with 5 µm diameter particles. 
Recently, our group has developed a mixer that is well-suited to mix reagents with 
effluent from a capillary column1, 36, 37. This mixer, in conjunction with a fused silica Capillary 
Taylor Reactor (a simple, open tube long enough to permit diffusional relaxation of radial 
concentration gradients1, 37), creates a v ery simple postcolumn reaction device that does not 
increase band spreading under the conditions used1. In this system, diffusion-controlled reactions 
occurred in times on the order of one second, in physical volumes on the order of 10 s of nL1, 37. 
Kinetically controlled reactions require longer reactors37. 
The magnitude of the inside diameter or radius of the post-column reactor is an important 
variable. It controls the reactor’s contribution to band spreading; smaller reactor radii are 
preferred from this perspective. However, as the HPLC column defines the flow rate, the 
pressure in the post-column reactor (of constant length) increases in inverse proportion to the 
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fourth power of the radius. Thus, there is clearly an optimal value for reactor radius. This paper 
determines that optimum, and demonstrates its dependence on c olumn diameter and particle 
diameter. 
3.2  Assumptions and Limitations 
In chromatographic theory, there are many variables. If the number of variables can be reduced, 
the essence of the theory is often made clearer. However, there is also a sacrifice in the breadth 
of applicability of the results from putting limitations on the system. Thus, it is important to state 
and discuss the limiting nature of the assumptions.  
We will set the value of three significant parameters by allowing them to depend on other 
freely chosen variables. One is the chromatographic velocity. We have set the velocity equal to 
the optimum velocity. Kennedy and Jorgenson38 have shown that the optimum velocity in 
capillary columns is a function of the column diameter. In this paper, we have not taken that 
subtlety into account. Further, there are several formulations of H vs. v curves39. We have chosen 
to use the van Deemter equation (the expression is shown later), which works acceptably near the 
optimum velocity. Another parameter that is set is the post-column reactor length. Both theory40 
and experiment1, 37 show that if the reaction is fast enough, it will be completed in a length of 
cylindrical tubing that depends upon the reagents’ diffusion coefficients, the tubing radius and 
the velocity. Furthermore, the velocity in the reactor depends on the chromatographic velocity 
(which we fix) and geometrical parameters. Finally, we have taken the k’ (the retention factor) of 
a solute to be zero.  
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The limitations that accompany these decisions are as follows. Setting the velocity at the 
optimum means that the analysis will favor total number of theoretical plates over theoretical 
plates per unit time. We analyze both in this paper. Setting the length of the post-column reactor 
means that the detector will give a ‘full signal’ for fast enough reactions, but not for kinetically 
slow reactions. Finally, the restriction on k’ will make the reactor’s relative (to the column) 
contribution to band spreading larger than it would be for a retained solute. A retained solute has 
a k’-dependent variance (time units). By using k’=0 in the formulations, we ignore this. The 
result is that the chromatography seems more sensitive to the presence of extracolumn band 
spreading than it would be for k’>0. 
Finally, we assume that the chromatographic system operates at the maximum pressure of 
the pumping system. The ultimate limitation to chromatographic throughput is pressure41. As the 
velocity is fixed at the optimum, we control the length of the chromatographic column to use the 
available pressure. 
In this paper, we determine how the system dimensions influence chromatographic 
performance as judged by the number of theoretical plates, N, and the number of theoretical 
plates per time. The results will show that there is an optimum in reactor radius that is dependent 
on the particle packing diameter and the column radius. Very small reactor radii lead to 
excessive pressure in the reactor, diminishing chromatographic performance by forcing a 
shortening of the column (remember, total pressure is fixed). Very large reactor radii lead to 
excessive band spreading in the reactor. 
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3.3 Equation Derivation 
3.3.1 Reactor Requires Pressure 
The total pressure in the system is given by Eq. (1). 
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Here, Pm is the maximum pressure of the HPLC pump, η is the viscosity of the mobile phase, Lc 
and Lr represent the length of the column and the reactor respectively, vc and vr are the average 
linear velocities in the column and the reactor, respectively, dp is the diameter of the packing 
particles, ar is the radius of the capillary used to make the reactor, and φ is the column’s 
permeability. The left-hand term on the right side is the pressure drop in the column41 while the 
right-hand term is the pressure drop in the reactor. We will now use the assumptions described 
above with the van Deemter equation to remove some of the variables.  
3.3.2 Average Velocity Is the Optimum Velocity. 
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++= λ             (2) 
In the van Deemter equation, Eq. 2, Hc is the height equivalent to a theoretical plate for the 
chromatographic column, D is the solute’s diffusion coefficient in the mobile phase, v is the 
average mobile phase velocity, dp is the packing particle diameter, and λ and g are numerical, 
geometry-dependent constants (values of such parameters are discussed below). We choose the 
optimal velocity as the column velocity.  
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vr is a function of vc and the ratio of ac, the radius of the column and ar. The factor b in Eq. 4 
below is equal to iee εεε )1( −+ , where εe is extraparticle porosity and εi is the intraparticle 
porosity. 
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3.3.3 Reactor Length Is the Length Required for Significant Diffusional Mixing. 
Lr, the length of the reactor, is given by Eq. (5)1, 37, 40. We fix Lr based on capillary Taylor theory1, 
37. The numerical factor represents the degree of mixing by diffusion. A larger number means 
more complete mixing. We choose 2.5 here, which means the length of the reactor is just enough 
for complete mixing. Kinetic factors are not considered here, thus extent of mixing is equivalent 
to the extent of reaction. 
D
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3.3.4 Revised Pressure Expression 
After substituting Eq. (3), (4) and (5) into Eq. (1), we obtain Eq. (6): 
2
42
3
)(40
2
pp
c
d
a
abgD
d
LDg
P r
c
m
η
ηφ
+=           (6) 
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The first term on the right hand side of Eq. (6) is still the pressure drop across the column (Pc) 
while the second term is that across the post column reactor (Pr). This equation can be recast into 
a dimensionless ratio of column pressure to available pressure to give Eq. (7). In Eq. (7), the 
dimensionless second term of the right hand side is the fraction of the available pressure needed 
by the reactor. 
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3.3.5 Reactor Adds Band Broadening. 
Band spreading occurs in the reactor, but it may not be significant if the chromatographic peaks 
are broad. Thus, we must compare the extent of broadening from both sources. We have already 
shown experimentally that the mixer portion of the mixer/reactor adds no measurable 
broadening1. The variance (in units of time squared) for the column (at the optimum velocity) is 
given by Eq. (8). 
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To get an expression for the variance, we will use the column length defined by pressure 
conservation (Eq. 9, from Eq. 6), 
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theoptimal velocity (Eq. 3) and the minimum value of Hc (Hmin, Eq. 10) derived from the 
optimum velocity and the van Deemter equation (Eq. 2). 
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After substituting Eqs. 3, 9 a nd 10 i nto Eq. 8, w e get the final description for the column 
variance. 
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3.3.6 Variance in the Reactor 
The variance in the same units for the reactor is given by Eq. (12)1. 
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Lr is defined above, and Hr is the height equivalent to a theoretical plate in a reactor1,  
DavH rrr 24/
2=             (13) 
3.3.7 Total Peak Variance 
The total peak variance is the sum of the column and reactor variances. 
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Here, we define M as
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The band broadening arising from the reactor can be considered negligible when it contributes no 
more than 10% extra to the peak width in the absence of the reactor. This is the case if
21.0/ 22 ≤cr σσ . 
3.3.8 Column Efficiency  
N is defined here as the number of theoretical plates from the column when using an ideal reactor 
that requires pressure but adds no ba nd spreading. The column variance, Eq. (11), is used to 
generate Eq. (15).  M is defined above. 
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However, with a postcolumn reactor, the retention time and the peak variance depend on more 
than just the column. The observed number of plates, Nobs, includes all effects of the reactor. 
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where, t0c and t0r are the dead time in the column and the reactor, respectively; M has the same 
definition as in Eq. (14); J represents the ratio ηgDPm / . 
Eq. (16) looks unwieldy. However, Nobs is only dependent on Pm and three size-related 
variables, dp, ac and ar. The figures based on these equations are much clearer. First, we will 
show the effect of column radius on the reactor choice. Secondly, we will find the relationship 
between Nobs and the variables dp and ar to get the optimal reactor radius for Pm equal to 4000 psi 
and ac equal to 50 μm. Finally, the effects of Pm on the reactor choice will be shown.  
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To display the effect of the reactor, we also calculate the number of theoretical plates of 
the column under the same conditions but without the reactor (N0) as below. Here, the pressure 
available for the column is the maximum offered by the pump.  
)24(
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0 gD
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λφη +
=              (17) 
 3.3.9 Description of Some Empirical Parameters 
There are many parameters in this calculation procedure. Here, we list the parameters and 
discuss their origin and value: the column’s permeability depends upon the method of packing 
and the particles for a packed column. For various columns, it ranges from 500 to 1000 41. We 
routinely obtain a value of 750 for 2.6 ~ 5 μm particle packings in 100 µm diameter columns.  
The effect of changes in φ on the results are negligible. λ and g are numerical, geometry-
dependent constants. Typically, λ is 2 and g is 30 [39]. The value 2 comes from experiment and 
the simple random walk approach to eddy dispersion. The number 30 comes from assuming that 
the C term is governed by di ffusional relaxation within the spherical particle. The value for 
λ will never be far from 2. The value for g would give a C-term in the Knox equation of 0.033, 
which is close to the observed value from many systems of C ~ 0.05. D is the diffusion 
coefficient of the solute in the mobile phase. η is the viscosity of the mobile phase. In our final 
expressions of Nobs, N and N0, D and η always appear as the product Dη for a given solute and at 
constant temperature, this product, sometimes called the Walden product ( aRTD πη 6/= where 
R is the gas contstant, T is the temperature, and a is the radius of the diffusing molecule), will 
remain fairly constant as the solvent changes. We used 5.0×10-10 m2/s as D and 0.001 N·s/m2 as 
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η. These values are typical for solutes of a few hundred Daltons molar mass and aqueous eluents. 
As the Walden product is in the final expressions, the product of these values is suitable for other 
solvents (but not dramatically larger or smaller solutes). b is equal to iee εεε )1( −+ , where εe is 
extraparticle porosity and εi is the intraparticle porosity. Usually, both porosities are near 0.4 39, 
so b is 0.64. This term is appropriate if the mean, not the extraparticle, velocity is used in the van 
Deemter equation.  O f all of the parameters, the value of g is the most dependent on t he 
particular system (particle shape, intra- vs. interparticle mass transport limitation, diffusional vs 
kinetic stationary phase mass transfer limitation).  
3.4 Results and Discussion 
3.4.1 Effect of Column Diameter: Is a Capillary Taylor Reactor Useful for Large Columns?   
The introduction discussed cases in which the simple Capillary Taylor Reactor added measurable 
band spreading with 4.6 and 1 mm ID columns. Table 3.1 provides a view of this problem. Table 
3.1 shows the effect of a Capillary Taylor Reactor on t he maximum number of observed 
theoretical plates, Max Nobs, as a function of dp and ac (Eq. 16). Values for N0, the number of 
theoretical plates generated by the capillary column without the reactor (Eq. 17), are also given. 
The ‘ar range’ is the range of reactor radii at which Nobs is at least 90% of N0.  The reactor can 
have a significant deleterious effect on the column efficiency. For a column having a radius of 
150 μm, the Max Nobs/N0 ratio increases from 19.5% to 99.9% as the diameter of packing 
particles increases from 1 μm to 5 μm. The influence of the reactor is small for the 2~5 μm 
particles but significant for 1 μm particles. The larger the column diameter is, the more effect the 
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reactor has on the column efficiency. The Max Nobs/N0 ratio decreases as column radius increases. 
The ar range in which Nobs/N0 is larger than 90% becomes narrow or even disappears as column 
radius increases. Therefore, a sm all column is preferred when used with a Capillary Taylor 
Reactor especially when the column is packed with small particles. Specifically, the effect of the 
reactor is negligible when column radius is smaller than 150 μm for particle diameters greater 
than or equal to 2 μm. 
 
Table 3.1 Effect of the column radius on Nobs/N0. Pm=4000 psi; D=5.0×10-10 m2/s; η=0.001 
N·s/m2; b=0.64; φ=750; g=30; λ=2. 
dp (μm) 1 2 3 4 5 
N0 3770 15100 34000 60400 94300 
ac = 150 μm 
Max Nobs 735 13600 33400 60100 94200 
ar range (μm) ----- 12 9-25 8-38 7-52 
Max Nobs/N0 19.5% 90.1% 98.2% 99.5% 99.9% 
ac = 500 μm 
Max Nobs 94 3600 25700 55600 91400 
ar range (μm) ----- ----- ----- 26-35 22-52 
Max Nobs/N0) 2.5% 23.8% 75.6% 92.1% 96.9% 
ac =1000 μm 
Max Nobs 68 535 10000 41600 82000 
ar range (μm) ----- ----- ------ ----- ------ 
Max Nobs/N0 1.8% 3.5% 29.5% 68.9% 86.6% 
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3.4.2 Optimization of the Reactor Radius for Capillary Columns with Various Particle 
Sizes. 
Figure 3.1 gives the relationship between the number of theoretical plates (N or Nobs) and the 
radius of the reactor ar for a 100 μm ID column (ac = 50 μm). N is the number of theoretical 
plates observed with a h ypothetical reactor that requires pressure but causes no extracolumn 
band spreading. Nobs is defined by Eq. (16). N and Nobs depend similarly on ar at small values of 
ar. N and Nobs sharply increase and then reach a plateau or maximum as ar increases. Larger 
particles exhibit a significant plateau, while the smallest particle size, 1 µm, shows a maximum. 
As ar increases beyond the maximum, N does not change at all while Nobs gradually decreases. 
The shape of Figure 3.1 can be understood qualitatively by considering system for large and 
small values of ar.  
There is a minimum value of ar that can be derived from Eq. 7. A s ar approaches 
cmp aPdbgD
4/122 ))/(40( η , more pressure is used to push fluid through the reactor. The column’s 
length approaches zero, so Nobs approaches zero as well. Thus, the effect of the reactor on the 
column efficiency as ar/ac approaches 4/122 ))/(40( mp PdbgDη  mostly comes from the pressure it 
steals. The pressure available to the column is increased with a larger diameter reactor, according 
to Eq. (7). For a large enough value of ar, it will approach Pm. However, when ar becomes large, 
the variance from the reactor becomes significant and cannot be neglected compared to the 
variance caused by the column. Nobs gradually decreases as ar increases as shown on the right 
hand side of Figure 3.1 because of the effect of the reactor variance (Eq. (12)).  
Obviously, what we are most interested in is the middle part of Figure 3.1 where the 
effect from the reactor is minimal and Nobs is the largest. Columns with larger packing particles 
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have a l arger column variance, so there is a wider region of conditions that allow the band 
broadening from the reactor to be negligible compared to that from the column. Therefore, 
columns with larger packing particles have a wider plateau. 
 
 
 
Figure 3.1 Plot of N (dashed line) and Nobs (solid line) against the radius of reactor. Each curve 
corresponds to a different particle diameter. The highest curve is for dp = 5 µm, and the lowest is 
for dp = 1 μm.  ac=50 μm; Pm=4000 psi; D=5.0×10-10 m2/s; η=0.001 N·s/m2; b=0.64;φ=750; g=30, 
λ=2.  
 
 
Table 3.2 lists the range of reactor radii that give a value of Nobs that is larger than 90% of 
N0, which we used to define the acceptable region. The parameters ‘Max Nobs’, ‘ar range’ and N0 
have the same definitions as i n Table 3.1. t0 is the retention time of an unretained solute. In 
addition, to determine whether it is possible to use a postcolumn reactor without significant 
sacrifice, Table 3.2 also compares Max Nobs with N0. Values of Max Nobs for particle sizes from 2 
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to 5 μm are all larger than 90% of N0. This is not the case with a 1 μm column, where Max Nobs is 
only 86.2% of N0.  This means that there is no reactor size that will yield an observed number of 
theoretical plates greater than or equal to 90% of N0. The variance from a 1 μm column is quite 
small and the variance from the reactor is never negligible. 
 
Table 3.2 Range of useful reactor radii with maximum Nobs as a criterion. ac=50 μm; Other 
conditions are the same as in Table 3.1. 
dp (μm) Max Nobs ar range (μm) N0 Max Nobs/ N0 t0 (s) 
1 3250 ------- 3770 86.2% 2.4 
2 15000 4~14 15100 99.3% 39 
3 34000 3~25 34000 100% 199 
4 60400 3~38 60400 100% 628 
5 94400 3~53 94400 100% 1533 
 
 
Large values of N are often accompanied by long experimental time which is also shown 
in Table 3.2. To get a different perspective, we also looked at Nobs per unit time (Nobs/t0) (Figure 
3.2). Figure 3.2 displays how Nobs/t0 changes with ar. From Figure 3.2, with a proper size reactor, 
the Nobs/t0 of a column with 1 μm particles can be more than four times larger than that of a 2 μm 
column, and over twenty times greater than a 5 μm column. Therefore, smaller particles are 
better in faster separations, even with a postcolumn reactor.  
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Figure 3.2 Nobs/t0  (s-1) as a function of ar. Conditions are the same as in Figure 3.1. 
 
Figure 3.2 is analogous to Table 3.2, but for the number of observed plates per time. It 
displays the range of ar that will yield Nobs/t0 that is at least 90% of N0/t0.  Note that the range is 
only slightly different from that for Nobs. Similar to Table 3.2, columns with large particles have 
a wider plateau for Nobs/t0.  
3.4.3 The Special Case of 1 μm Particles: Is a Smaller Column Better When Using a 
Reactor?   
As mentioned before, the reactor always affects the observed chromatographic efficency when dp 
is 1 μm (as shown in Figure 3.1, there is no plateau there at dp=1μm and Table 3.2, Nobs/N0 
always smaller than 90%). This is because the column variance from a 1 μm column is extremely 
small so that the variance from the reactor cannot be neglected. The only way to minimize the 
variance from the reactor is to use small radius reactors, which will be accompanied by a 
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sacrifice in available column pressure. However, Eq. (7) tells us that the pressure drop for the 
column will not change if ac/ar and dp are constant. Therefore, for a given particle diameter, if 
the column diameter is scaled down as the reactor diameter is scaled down, the fraction of the 
maximum pressure available for the column should remain constant. That means when the 
column diameter is reduced, the reactor diameter should be reduced proportionally. Therefore, 
using a smaller column diameter might be helpful. 
 
 
Figure 3.3. Plot of Nobs against the diameter of the post-column reactor. dp=1 μm; ac is altered 
from 25 to100 μm. The solid line represents Nobs while the dashed line represents N0. Other 
conditions are the same as in Figure 3.1. 
 
Figure 3.3 shows curves of Nobs for 1 µm particle packing plotted against reactor radius 
with column radius as a parameter. In Figure 3.3, the curves of Nobs vs. reactor radius increase 
sharply, reach a maximum and then gradually decrease at larger reactor radii. The maximum 
value of Nobs increases more than two times and the optimum value of ar becomes smaller as the 
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column diameter changes from 100 μm to 25 μm. When the column radius is equal to or less 
than 42.5 μm, the Max Nobs/N0 ratio starts to approach 90%, which means the reactor’s effect is 
negligible at the optimal radius of the reactor, which is 5 μm. 
3.4.4 Maximum Pressure (Pm) and Optimal Reactor Radius. 
Results shown in Table 3-4 indicate the effect of Pm. Max Nobs, the maximum value of Nobs under 
optimal conditions, increases almost proportionally as Pm increases. The ‘ar range’ increases 
slightly as Pm increases. However, ar, the reactor radius at which the maximal Nobs is achieved, is 
independent of Pm. 
 
Table 3.3 Effect of the Pm on the acceptable range of reactor radii when ac=50 μm. Other 
conditions are the same as in Table 3.1. 
dp (μm) 1 2 3 4 5 
Pm=2000 psi 
Max Nobs 1400 7500 17000 30200 47200 
ar (μm) 5 7 10 12 14,15 
ar range (μm) ----- 5-12 4-22 3-32 3-45 
Pm =4000 psi 
Max Nobs 3250 15000 34000 60400 94400 
ar (μm) 5 7 10 12 14,15 
ar range (μm) ----- 4-14 3-25 3-38 3-53 
Pm= 8000 psi 
Max Nobs 7000 30100 67900 121000 189000 
ar (μm) 5 7 10 12 14,15 
ar range (μm) 5 3-16 3-29 3-44 2-61 
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3.5 Conclusion 
In this paper, the influence of the diameter of a Capillary Taylor Reactor on the performance of 
capillary liquid chromatography was studied. The reactor steals pressure from the column which 
in turn decreases the numbers of theoretical plates when small reactor diameters are used. At the 
same time, it adds some band broadening. The choice of the reactor radius actually depends on 
several factors such as packing particle size, maximal available pressure and column diameter. 
For packing particles larger than or equal to 2 µm, the Capillary Taylor Reactor is suitable for 
columns with radii not larger than 150 µm (For “suitable”, we defined as if Nobs/N0 > 90%). A 
reactor with about a 12 µm radius (i.e., the commercially available 25 µm ID capillary) works 
well under such conditions. For 1 µm particles, however, the requirements are more stringent. 
Only columns with smaller than 42.5 µm radii can be used and the optimal reactor radius is 5 µm, 
which is much smaller compared to those coupled with larger particle packing columns. The 
results above are obtained under a maximal pressure of 4000 psi. The limitations in the column 
diameter become less restricted when a higher maximum pressure is available. 
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Chapter 4. Effect of an Open Tube in Series with a Packed Capillary Column 
on Liquid Chromatographic Performance. The Influence of Particle Diameter, 
System Pressure, and Temperature. 
This work has been published on J. Chromatogr. A 2009, 1216, 1346-1352. 
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4.1 Introduction 
It is well known that postcolumn reactions can improve sensitivity and selectivity in liquid 
chromatographic analysis1-3. Although postcolumn dead volume is not always deleterious to a 
separation, when the highest efficiency-per-time is needed, postcolumn dead volume may be 
limiting. Thus, postcolumn reactors come with some disadvantages. The most obvious are the 
additional hardware and reagents required, and the bandspreading associated with the additional 
mixing following the separation. The bandspreading issue has been addressed theoretically4 as 
well as ex perimentally5,6. Optimization of postcolumn conditions for chemiluminescence 
detection has been achieved7. Much of the published work applies to columns with typical 
dimensions of 4.6 mm ID, 10-20 cm long with 5 µm diameter particles.  
In the past several years, HPLC has taken a dramatic step towards fast separations. Both 
the A term and the C term of the van Deemter equation decrease as dp decreases. This drives the 
need for higher pressure capability because the smaller dp increases back pressure at constant 
velocity. High pressure pumps permit the application of smaller dp and higher flow rate at the 
same time. Numerous particles with sub-2 µm diameter and superior mechanical and chemical 
stability are present in the market8. High temperature HPLC has also attracted interest8-11. High 
temperature decreases the viscosity of the mobile phase and accelerates mass transfer, both of 
which can lead to faster separations without sacrificing column efficiency12. Among the 
commercially available sub-2 µm packing particles, BEH-C18
13, BEH-Shield RP18 
10 and Zorbax 
Stable Bond particles14 (Zorbax SB-C18, -C8, CN, C3, -Phenyl) have shown excellent thermal 
stability. Thanks to these emerging materials, high temperature becomes a very promising 
parameter in HPLC for fast analysis. These advances help to speed up HPLC and shorten 
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analysis time to minutes or even seconds rendering HPLC a potential method for on-line 
monitoring and high-throughput analysis. 
In a previous paper15, we studied the influence of the radius of an open tube reactor, 
which we call a Capillary Taylor Reactor or CTR, on t he performance of capillary liquid 
chromatography where the linear flow rate of the mobile phase is the optimum and the solute k’ 
is 0. The choice of the reactor radius actually depends on several factors such as particle size, 
maximum available pressure, and column diameter. With a maximum pressure of 4000 psi and 
for packing particles larger than or equal to 2 µm, the CTR is suitable for columns with radii less 
than 150 µm (“suitable” is defined as Nobs/N0 > 90% where Nobs is the column efficiency with a 
CTR while N0 is that without a CTR). A reactor with a 12.5 µm radius (i.e., commercially 
available 25 µm ID capillary) works well under such conditions. For 1 µ m particles, the 
requirements are more stringent. However, the assumptions of operating at the optimum velocity 
and with k’ = 0  are unrealistic. Therefore, it is necessary to ask: how does a C TR affect the 
performance of a capillary column in fast separations under realistic conditions? 
We will use the Poppe plot, simple but powerful, to analyze our results.  I t is a log-log 
plot of the plate time (time equivalent to a theoretical plate, TETP, t/N) vs. the plate number (the 
number of theoretical plates, N)16. Isochrones of constant t are easily drawn on the same plot. 
Thus, a Poppe plot directly gives not only the number of theoretical plates under certain 
conditions but also the related analysis time (if k’ is known). Short analysis time and a large 
number of theoretical plates are both desirable but hard to achieve together. With a Poppe plot, it 
is easy to consider both of them and make a choice depending on what is more important in a 
specific experiment: the analysis time or the column efficiency. 
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In this paper, we derived an equation that defines the observed number of theoretical 
plates (Nobs) from a column and CTR with minimal assumptions. We have focused the study on 
fast separations by i nvestigating three emerging, important parameters in fast HPLC, namely 
small porous packing particles, high temperature, and high obtainable pressure. By comparing 
the column efficiency with and without a reactor, we have found that a 5 µm radius reactor is the 
best for unretained or slightly retained solutes at room temperature. At elevated temperature, the 
much more practical 12.5 µm radius reactor works. A 12.5 µm radius reactor is actually slightly 
better than a 5 µm reactor for retained solutes. 
 
4.2 Scheme of the Set Up of a Packed Capillary Column in Series with a CTR  
 
Figure 4.1 Scheme of the set up of a packed capillary column in series with a CTR.
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4.3 Theory 
A CTR affects column efficiency in two ways: adding band-spreading and requiring pressure. 
There is no doubt that adding band-spreading damages column efficiency. For a sy stem 
operating at the maximum attainable pressure, sharing pressure decreases performance for the 
following reason. A higher pressure drop across the reactor leads to less pressure available for 
the column which forces a decrease in the linear velocity (longer analysis time) or the length of 
the column (fewer theoretical plates). The latter problem gets worse for reactors with small 
radius. Therefore, we derived Nobs, the observed number of theoretical plates considering these 
two effects from a reactor as follows.  
4.3.1 The Linear Velocity in the Column in the Presence of a CTR  
The total pressure in the system is given by Eq. (1). The first term on the right side of equation is 
the pressure drop in the column while the second term is the pressure drop across the reactor. 
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In Eq. (1), Pm is the maximum pressure provided by the pump;φ  is the column permeability; η is 
the viscosity of the mobile phase; ar is the radius of the capillary used to make the reactor; uc and 
ur are the average linear velocities in the column and the reactor, respectively; Lc and Lr represent 
the length of the column and the reactor, respectively. The value of φ  ranges from 500 to 1000 
for various columns17, and we routinely obtain a value of 750 for 2.6 ~ 5 μm particle packed 
columns with a diameter of 100 µm. Changing φ  has a negligible effect on the choice of reactor 
radius as described in a previous paper [15]. ur can be written as a function of uc as 
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When mixing, a post column reagent flow is introduced into the reactor capillary, increasing the 
flow rate. In our laboratory, the reagent flow rate is set to be 1/4 ~ 1/2 of the column flow rate to 
obtain the best sensitivity. Here, we chose 1/3. That is the origin of the constant, 4/3, in Eq. (2a). 
The column radius is ac ; eε is the extraparticle porosity and iε is the intraparticle porosity. Both 
porosities are around 0.4 18, consequently b is 0.64. 
The following relationships hold for Lc and Lr   
0tuL cc =            (3) 
DayuL rrr /
2=           (4) 
where t0 represents the void time of a separation and y describes the degree of mixing by 
diffusion. More complete mixing has a larger y value. We chose a value of 2.5 here. This value 
gives a reactor length that results in a dispersion coefficient defined by the Taylor equation19. 
When the capillary is operating in the Taylor region, the length must be sufficient for an 
effectively complete reaction if the reaction rate is not the limiting factor20. Chemical kinetic 
factors are not considered here. D is the diffusion coefficient of the solute in the mobile phase. 
Combining Eqs. (1)-(4), we obtain the expression to define the average linear velocity in column: 
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The viscosity of the mobile phase in units of Pa⋅s is a function of temperature T (in Kelvin) as 
shown in Eq. (6)21. 
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where xacn is the volume percentage of acetonitrile in the mobile phase. We chose 23% in this 
paper. Another factor dependent on temperature is D, the diffusion coefficient of the solute in the 
mobile phase, 
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which is derived from the Walden product, constant/ =TDη . In this paper, we chose D0 to be 
7.0 ×10-10 m2/s at 293 K to represent a low molecular weight solute.  
With moderate manipulation, an expression for uc is obtained as a function of Pm, dp, ar, 
ac, t0 and T as shown in Eq. (8). 
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4.3.2 Column Efficiency with a CTR   
We used the van Deemter equation to define Hc, the height equivalent to a theoretical plate, for 
the case in which the ‘C term’ is dominated by intraparticulate mass transfer. 
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where λ  and g are numerical, geometry-dependent constants. Typically λ  is 2 and g is 3018 for 
spherical particles. ue is the extraparticle linear velocity and k″ is the zone capacity factor. k″ 
relates to k΄, the retention factor, by ')1(" 00 kkkk ++= , where k0 is equal to eie εεε /)1( − , and 
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has a constant value of 0.6 if the porosities are set to 0.4.  The extraparticle velocity ue is defined 
as cuk )1( 0+ .  
Hc can be calculated provided that uc is known from Eq. (8). The variance from a column 
in the units of time squared then can be determined by Eq. (10). 
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Eq. (11) is Hr, the height equivalent to a theoretical plate in a reactor1. 
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The variance in time units for a reactor is given by (using Eqs. (4) and (11))  
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Therefore, the observed number of plates, Nobs, including both effects of the reactor, is expressed 
as 
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where te is the dead time for a species that remains in the flowing mobile phase and tr is the time 
to pass through the  CTR: 
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For the sake of clarity, an example is given here to illustrate the calculation. With a dp of 
1.7 µm, an ar of 12.5 µm, an ac of 50 µm, a t0 of 5 s , a T of 293 K and a Pm of 4000 psi, we 
calculated the average linear velocity to be 4.5 ×10-3 m/s based on Eq. (8). We then obtained the 
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values of  Hc, σc,t2  and σr,t2 for an unretained component (k″= 0.6) according to Eqs. (9), (10) and 
(12) as 3.8 ×10-6 m, 4.3×10-3 s2 and 5.6×10-3 s2, respectively. Finally, we calculated Nobs and 
t/Nobs based on Eq. (13). They are 3155 and 1.8 ×10-3 s. For a set of t0 values, we obtain a set of 
Nobs and t/Nobs values which results in one Poppe plot.  
4.3.3 Column Efficiency Without a CTR   
To display the effect of the reactor, we also calculate the number of theoretical plates under the 
same conditions but without the reactor (N0) as shown below. The derivation procedure is similar 
to the one with the reactor but it ignores the reactor part.  
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where ue0 is defined as 00 )1( uk+ . 
4.4 Assumptions and Approximations 
As in any approach to a quantitative analysis of a complex system, approximations and 
assumptions have been made. There are four choices we have made that require at least a brief 
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discussion; namely, the reagent flow rate, the choice of what expression to use for plate height, 
whether Taylor dispersion is a good description of what occurs in the reactor, and what diffusion 
coefficient to use. 
First, let us consider the reagent flow rate. There is not a co rrect choice here, but it is 
certainly true that using a minimal flow rate is best to avoid dilution. Consequently, we have 
chosen the flow rate of the reagent to be 1/3 of that of the column. This happens to match the 
current practice in our laboratory. Next, let us consider which bandspreading equation to use. 
Here we made two choices. First, we chose the van Deemter equation. Furthermore, we chose to 
take only a single C-term representing intraparticle diffusion. Both of these choices can be 
criticized from the perspective that they may not be accurate for a particular set of circumstances. 
In our view, there are several reasons to support these choices. For one thing, the choice is 
convenient. To the degree that one would like to manipulate algebraic expressions for 
understanding, it becomes easier with the algebraically simple van Deemter equation, as it has no 
fractional powers of velocity. Also, we have a previous related publication using the same van 
Deemter equation. Continuing to use the van Deemter equation makes the comparison of this 
work and the published work more convenient. Finally, and most importantly, the choice does 
not matter much. For the most part, in this work we will compare performance of a column with 
a reactor to a column without a reactor. Further, we mostly focus on changes induced by altering 
temperature and pressure, and those effects as a function of reactor capillary radius, and over 2-3 
orders of magnitude of time (t0). For this broad perspective, the differences among the 
approaches to describe H disappear. Last, we must consider issues surrounding the use of Taylor 
dispersion to describe bandspreading in the tubular post-column reactor. When experimental 
conditions are in the Taylor dispersion region, a uniform mixing zone without a radial 
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concentration gradient will be formed. Therefore, in the Taylor region, the reagent stream and 
the analyte stream will be thoroughly mixed. We have assumed a rapid reaction, rapid enough 
that reaction occurs faster than mixing. Under this assumption, the reactor’s efficacy is related to 
the system being adequately described by Taylor dispersion. There are two criteria for being in 
the Taylor region: Pe = ua/D >70, which guarantees the axial molecular diffusion is negligible 
compared to the total dispersion effect (that is, the system is not in the Taylor-Aris region), and  
Pe < 0.4 L/a to make sure that the reactor tube is long enough for the diffusion to relax the radial 
concentration gradient19. In our calculations, the reactor length is chosen to satisfy the criterion 
that Pe equals 0.4 L/a (Eq. 4 above). Under all the conditions that we will explore below, Pe is 
larger than 70, so the reaction capillary is theoretically in the Taylor region. We have already 
demonstrated that the reactors obey Taylor dispersion theory1, and the bandbroadening 
contribution from the mixing portion of the reactor (i.e., the point of mixing of the streams, 
changes in tubing diameter etc.) is actually immeasurable. Thus, the reactor behaves like a 
Taylor reactor theoretically and experimentally. There is one final caveat and discussion that is 
related to the diffusion coefficient. The caveat is that the calculations below assume a fairly 
small molecule. The results may be different if the solute is a 100 kDa protein, for example. The 
discussion is related to the fact that there are actually two important diffusing species, the solute 
that elutes from the column and its reaction product (creating a d etectable species). We have 
assumed that the diffusion coefficients of the solute and the detected species are the same. For 
example, we use Cu(II) as a r eagent for peptides22. The small change in molecular weight will 
not alter the diffusion coefficient considerably. Finally, we have assumed that the diffusion 
coefficient does not change when the chromatographic eluent and the reagent stream combine. 
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This may or may not be significant, depending on the actual conditions. In this paper, we have 
not incorporated this effect because there is little to be gained from the added complexity. 
4.5 Result and Discussion 
4.5.1 The Effect of a 25 µm CTR on the Performance of HPLC 
Before turning to Poppe plots, it is informative to understand the magnitude of the problem. 
Figure 4.2 shows the effect of a reactor with a radius of 25 µm (which is easily fabricated in the 
laboratory) on t he column efficiency. Nobs, defined by E q. (13), is the number of theoretical 
plates with the reactor’s effects taken into account while N0, defined by Eq. (17),  is the number 
of theoretical plates generated by the same column but without a reactor. When Nobs/N0 is greater 
than or equal to 90%, we consider the effect of the reactor to be acceptable throughout this paper. 
As shown in Figure 4.2, Nobs/N0 is at best 73% for columns packed with particles of diameters 
ranging from 1 µm to 5 µm for a separation with a t0 of 50 s. It becomes even smaller as analysis 
speed is increased. Column efficiency is reduced to less than 14% at a t0 of 5 s which is not 
tolerable. Thus, it is necessary to optimize the conditions to minimize the effect from a C TR 
especially when speed is required. 
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Figure 4.2 The effect of a 25 µm CTR on column efficiency (Nobs/N0 vs t0) when the packing 
particle diameter ranges from 5 µm to 1 µm (up to bottom from the left). Conditions are as 
follows: Pm = 4000 psi; b = 0.64; φ = 750; g = 30; λ= 2; ac = 50 µm; ar = 25 µm; T = 293 K; k″ = 
0.6 (k’= 0). 
4.5.2 Optimization of CTR Radius   
The effect of reactor radius on efficiency is shown in Figure 4.3. The curves representing the 
four reactors are all more or less far away from the dashed line (no reactor) with a short analysis 
time while becoming closer to the dashed line when the analysis is slower. Some of them even 
overlap the dashed line when the analysis time is long enough which means that the effect from a 
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CTR can disappear when the separation is slow enough. Among them, the 5 µ m curve is on 
average closest to the dashed line, especially at small t0. Therefore, a reactor with a radius of 
about 5 µm has the least effect on the column efficiency. The 1 µm reactor line is exceptional. It 
is always far away from the dashed line with a t0 ranging from 1 to 200 s. 
 
Figure 4.3 Poppe plots for reactors with various radii. dp= 1.7 µm and other conditions are the 
same as in Figure 4.2.  
 
Figure 4.4 and Figure 4.5 demonstrate how the reactor affects the column efficiency and 
how these effects are related to the reactor radius and the analysis time of a separation. Pr is the 
pressure drop across a reactor (the second term of Eq. (1)). 2,trσ  is the variance in the reactor 
calculated from Eq. (12) and 2,tcσ is the variance in the column calculated from Eq. (10). 
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Obviously, large diameter reactors require less pressure and leave more pressure to the column 
which in turn gives a better separation (Figure 4.4). On the other hand, large reactors contribute 
more to bandspreading which hurts the column efficiency (Figure 4.5). However, both effects 
have one thing in common: they get smaller at longer analysis time. That is, the reactor’s effect 
on the column efficiency is more critical in fast separations. 
 
Figure 4.4 Pressure drop across the reactor as a fraction of the attainable pressure as a function 
of t0. Curves for various reactor radii are labeled. Other conditions are as the same as in Figure 
4.3. 
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The bandspreading caused by a 1 µm reactor is negligible.  The effect of a 1 µm reactor 
on the column efficiency then mainly comes from the pressure it requires. As shown in Figure 
4.4, the pressure drop across a 1 µm reactor is more than 84% of the maximum pump pressure in 
a t0 range of 1 s to 100 s. The column efficiency in this case is comparable to that generated on 
the same column operated at less than 16% of the total pressure in the absence of a reactor. That 
explains why the 1 µm line (Figure 4.3) is always far from the dashed line (no reactor). On the 
other hand, the pressure drop across a 25 µm reactor is negligible according to Figure 4.4, so that 
the effect of a 25 µm reactor on the column efficiency is mostly caused by bandspreading. As 
shown in Figure 4.5, the band spreading occurring in a 25 µm reactor is almost equal to the total 
bandbroadening at a t0 shorter than 10 s an d it gradually decreases with an increase of the 
analysis time. This explains why in Figure 4.3 the 25 µm curve becomes closer to the ‘no reactor’ 
curve as the analysis time gets longer. Figure 4.3, 4.4 and 4.5 show that, for large enough t0, the 
effects of 5 a nd 12.5 µ m reactors on both pressure and bandspreading are small. For 5 µ m 
reactors, Nobs/No is greater than 0.93 for a t0 greater than 5 s. The same is true for 12.5 µ m 
reactors when t0 is longer than 25 s. Unfortunately, a 5 µm radius reactor would be very difficult 
to manufacture. 
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Figure 4.5   Variance in a p ostcolumn reactor as a f raction of the total variance vs. t0 for 
unretained solutes. Curves corresponding to various reactor radii are labeled. The conditions are 
the same as in Figure 4.3.  
4.5.3 Minimize Reactor Effect by Increasing Temperature  
Temperature is a v ery powerful parameter in fast HPLC12. The viscosity of the mobile phase 
decreases at elevated temperature, so does the pressure drop across the reactor. The diffusion 
coefficient of a so lute in the mobile phase increases so that the bandspreading in the reactor 
decreases for velocities greater than the optimum velocity. Temperature should have an influence 
on the effect of the reactor on efficiency.  
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Figure 4.6 Poppe plots at different temperatures. Solid curves represent the results with a 12.5 
µm reactor while dashed curves represent those without a reactor. Other conditions are the same 
as in Figure 4.3. 
 
Figure 4.6 shows Poppe plots at three different temperatures with or without a 12.5 µm 
reactor. Obviously, increasing the temperature helps to minimize the effect from the reactor 
because the solid curves are closer to the related dashed line at high temperature at a given 
analysis time, e.g. t = 10 s. The valule of Nobs/No increases to 93% at 353 K and a t0 of 10 s from 
73% at 293 K. 
Table 4.1 shows the percentage of the total variance that comes from the reactor at four 
temperatures and three values of t0. The higher the temperature or the larger t0 is, the smaller the 
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effect from the reactor on the bandbroadening. The change in the reactor effect caused by 
increasing temperature is dramatic. With a t0 of 5 s , the added bandbroading from a 12.5 µ m 
reactor decreases from 57% to 15% when the temperature is increased from 293 K to 373 K. 
With a t0 of 10 s , this number decreases from 32% to 6%. Therefore, high temperature 
significantly minimizes the effect of a 12.5 µm reactor on bandbroadening which in turn is of 
benefit to column efficiency.  
Table 4.1 Temperature minimizes the effect of a 12.5 µm reactor on bandbroadening. Pm= 
4000 psi; b= 0.64; φ= 750; g= 30; λ= 2; ac= 50 µm; ar= 12.5 µm; k″=0.6 (k’=0) 
 
)/( 222 crr σσσ +  (%) 
 T = 293 K T = 313 K T = 353 K T = 373 K 
t0 = 5 s 57 42 21 15 
t0 = 10 s 32 21 9 6 
t0 = 30 s 8 5 2 1 
 
 
4.5.4 Reactor Effect at Different Maximum Pressures    
According to the van Deemter equation, the A and C terms decrease as p article size (dp) 
decreases. The right side of the van Deemter curve where the C-term dominates becomes flatter 
indicating that for small dp, column efficiency is not compromised too much at high velocities. 
However, small particles and high velocities lead to high pressure drop across the columns 
suggesting that high pressure is advantageous for fast separations. 
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Figure 4.7 Poppe plots at different pressures. Solid line represents the results with reactors (solid 
line with triangles is with a 12.5 µm reactor; solid line without symbols is with a 5 µm reactor) 
while dashed line represents those without a reactor. Temperature and pressure are indicated. 
Other conditions are the same as in Figure 4.3.  
 
Figure 4.7 shows how a CTR impacts column efficiency at various available pressures. 
Reactors affect the column efficiency in a similar way at all pressures: the effect of a reactor is 
larger at shorter analysis time. Operating at higher attainable pressure obviously gives better 
separation without a reactor as the dashed plots show. With a dead time of 5 s  and at room 
temperature, the column efficiency at 12000 psi is almost twice that at 4000 psi. The advantage 
brought by the high pressure almost disappears with a 12.5 µm reactor at a t0 of 10 s. The column 
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efficiency is only 39% of N0 at 12000 psi with a 12.5 µm reactor with a t0 of 5 s and it is even 
worse than that at 4000 psi without a reactor. With a 5 µm reactor, it gets better. The column 
efficiency only decreases a small amount, from 93 % to 92% of N0 when pressure increases from 
4000 psi to 12000 psi. Increasing the temperature greatly improves the column performance with 
a CTR, as shown in the bottom set of curves. The effect from a 5 µm reactor almost disappears at 
373 K. The column efficiency with a 12.5 µm reactor also exceeds 90% at a t0 of 10 s  at this 
temperature. Therefore, to maximize the benefit of ultra high pressure, elevated temperature 
combined with a small radius reactor is certainly preferred.  
4.5.5 Reactor Effect is Minimized for Retained Solutes.   
Band spreading occurs in the reactor, but it is not significant if the bandspreading on the column 
is significant. The peak for a retained solute is obviously more broadened than that for an 
unretained solute. Thus, we have studied the reactor effect when solutes are retained. The results 
are shown in Figure 4.8 where solid lines represent the contribution of the reactor with various 
radii to the bandbroadening and dashed lines show the corresponding ratio of column efficiency.  
The effect of a reactor with smaller radius (1 µm or 5 µm) on bandbroadening is negligible . The 
bandbroadening effect of a reactor with a manageable radius (12.5 µm or 25 µ m) greatly 
decreases and starts to disappear when retention gets larger. The variance of a 12.5 µm reactor 
decreases from 32% (k” = 0.6, shown in Figure 4.5) of the total variance to only 5% (k” = 3.8) 
with a t0 of 10 s. The situation is almost the same for a 5 µm reactor. Furthermore, a 12.5 µm 
reactor requires much less pressure than a 5 µm reactor does (shown in Figure 4.4). This implies 
that a 12.5 µm reactor could be better than a 5 µm reactor for retained solutes in fast separations. 
This notion is verified by the dashed lines. A 12.5 µm reactor starts to supersede a 5 µm reactor 
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with a t0 longer than 5 s when k” equals 3.8 (or k’ equals 2). Even a 25 µm reactor is suitable 
with a t0 longer than 27 s as indicated by the shaded portion of Figure 4.8.  
 
Figure 4.8 Contribution of a reactor with various radii to the band spreading (expressed as 
( ))/ 2,2,2, tctrtr σσσ +  of moderately retained solutes (k″ = 3.8) (solid line) and corresponding Nobs/N0 
(dashed line) with a t0 ranging from 1 s to 150 s (triangle denotes the 25 µm radius reactor; circle 
is 12.5 µm; rectangular is 5 µm; no symbol is 1 µm). Shadow indicates where the reactor has 
negligible effect on column performance. Other conditions are the same as in Figure 4.3. 
4.5.6 Practical Limitations  
Theoretical calculations demonstrate that high pressure and elevated temperature greatly 
increases the column efficiency in fast separations not only by allowing the use of small packing 
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particles and high velocity of the mobile phase at the same time but also by di minishing the 
reactor effect. High pressure pumps are now commercially available. Particles with superior 
mechanical,chemical, and thermal stability are present in the market8, 14. The fabrication of a 
CTR is now the only practical limitation. The construction of a CTR was described elsewhere1. 
Briefly, two tungsten wires are each threaded into two capillaries and then both into another 
capillary. The junction between the three capillaries is then placed into a piece of PTFE/FEP dual 
shrink/melt tube. When heating, the outer PTFE layer starts shrinking and the inner FEP layer 
starts melting. After cooling down, the tungsten wires are removed and a CTR is formed. Small 
tungsten wires curl up leading to the difficulty in preparation of a CTR with small radius. This 
again explains why we pursue suitable conditions so that a 12.5 µm radius reactor can be used. 
The other limitation of CTR fabrication is the length. According to our experience, the length of 
a CTR cannot be shorter than about 1 cm because of the presence of the dual shrink/melt tube.  
In this paper, we used Taylor dispersion theory to define the length of the reactor. It is 
interesting to consider the length of the reactor and the column that arises in a ‘high performance’ 
scenario. Figure 4.9 displays the length of a 100 µm (ID) column packed with 1.7 µm particles 
and a 12.5 µm (radius) reactor at 12000 ps i and 373 K  and the corresponding number of 
theoretical plates. It is noteworthy that these conditions lead to about 20,000 theoretical plates at 
a t0 of 10 s.  Furthermore, both lengths are greater than 2 cm with a dead time shorter than 10 s 
so that we can directly apply the optimal calculated parameters for such separations. However, 
for separations with longer t0 (>10 s), the reactor length needed for complete mixing is actually 
less than 2 cm in theory. Experimentally, a longer reactor may be preferred for practical reasons 
which may increase bandbroadening in the reactor. The column efficiency may then be worse 
than expected from theory. 
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Figure 4.9 Lengths of a reactor with a radius of 12.5 µ m (dashed line) and a 100 µm (ID) 
column packed with 1.7 µm particles (solid line) and corresponding Nobs vs. t0 at a temperature of 
373 K and a pressure of 12000 psi. Other conditions are the same as in Figure4.3.  
 
4.6 Conclusion 
A postcolumn open capillary, including a postcolumn reactor, steals pressure from the column 
which in turn decreases the number of theoretical plates when a small radius capillary is used. At 
the same time, it adds band broadening especially when a l arge radius capillary is used. Such 
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effects become more intolerable as the separation goes faster. For a 1.7 µm dp column (100 µm 
ID) with a pressure of 4000 psi and at room temperature, a 5 µm radius reactor is the best for 
unretained species, but such a small radius reactor is hard to fabricate and maintain. Fortunately, 
higher temperature helps to minimize the reactor’s effect so that an easily fabricated 12.5 µm 
radius reactor is suitable in fast separations. The reactor’s effect is relatively smaller for retained 
species due to their larger on-column band broadening compared to unretained species. For a 
moderately retained species, a 12.5 µm reactor becomes even better than a 5 µm reactor at a t0 
longer than 5 s  when other conditions are the same. Ultra-high pressure greatly increases the 
column efficiency but this benefit is lost especially for unretained or slightly retained species 
when a 12.5 µm reactor is used. To take full advantage of high pressure with a 12.5 µm reactor, 
higher temperature is a must. At a t0 of 5 s, a pressure of 12000 psi, room temperature and with a 
12.5 µm reactor, Nobs/N0 is only 39% for an unretained solute. Under the same conditions but at a 
temperature of 373 K, Nobs/N0 increases to 81% and 99% for unretained and moderately retained 
solutes (k” = 3.8, k’ = 2), respectively. Therefore, a capillary HPLC column followed by a CTR 
with manageable radius (larger than 12.5 µ m) gives best column efficiency for moderately or 
strongly retained solutes at high pressure coupled with high temperature. 
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Conclusion 
We have developed a novel sampling method based on e lectroosmosis and applied it to draw 
physiological fluid through the extracellular space of an OHSC. We have characterized this new 
sampling method by m easuring the flow rate, examining the use of internal standards, and 
examining cell death caused by sampling. The sampling flow rate ranges from 60 to 150 nL/min 
with a 150 µm (ID) sampling capillary and an electric field (at the tip of the capillary) from 30 to 
60 V/cm. Cell death can be negligible for a sampling time of 5 min at a moderate electric field 
with the sampling capillary tip 50 µm away from the slice culture surface. Using this sampling 
approach, we have electroosmotically pulled Leu-enkephalin through OHSCs to identify 
ectopeptidase activity in the CA3 region. These studies show that a b estatin-sensitive 
aminopeptidase may be critical for the hydrolysis of exogenous Leu-enkephalin, a neuropeptide 
present in the CA3 region of OHSCs.  
We have not determined the spatial resolution here quantitatively. We estimate, based on 
the images of tissue damage (when it occurs) that the spatial resolution is on the order of several 
hundred micrometers. This will need to be studied more rigorously in the future.  
Electroosmotic sampling appears to be effective. The approach is simple and ideal for 
sampling through slices with a thickness of only 150 µm and from the surface of an organ as 
well. In vivo application can be envisioned with narrower or pulled capillaries. Electroosmotic 
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sampling could be employed to study ectopeptidase activity in intact tissue with high spatial 
resolution. Electoosmotic sampling also could find its application in extracellular endogenous 
peptide extraction and determination when combined with appropriate quantitative analytical 
approaches.  
We have investigated the effect of a postcolumn open capillary, including a postcolumn 
reactor, on the performance of a cap illary column. A capillary Taylor reactor (CTR) steals 
pressure from the column which in turn decreases the number of theoretical plates when a small 
radius capillary is used. At the same time, CTR adds band broadening especially when a large 
radius capillary is used. Such effects become more intolerable as the separation goes faster. For a 
1.7 µm dp column (100 µm ID) with a pressure of 4000 ps i and at room temperature, a 5 µm 
radius reactor is the best for unretained species, but a reactor with such a small radius is hard to 
fabricate and maintain. Fortunately, higher temperature helps to minimize the reactor’s effect so 
that an easily fabricated 12.5 µm radius reactor is suitable in fast separations. The reactor’s effect 
is relatively smaller for retained species due to their larger on-column band broadening 
compared to unretained species. For a moderately retained species, a 12.5 µm reactor becomes 
even better than a 5 µm reactor at a t0 longer than 5 s when other conditions are the same. Ultra-
high pressure greatly increases the column efficiency but this benefit is lost especially for 
unretained or slightly retained species when a 12.5 µm reactor is used. To take full advantage of 
high pressure with a 12.5 µm reactor, higher temperature is a must. At a t0 of 5 s, a pressure of 
12000 psi, room temperature and with a 12.5 µm reactor, Nobs/N0 is only 39% for an unretained 
solute. Under the same conditions but at a temperature of 373 K, Nobs/N0 increases to 81% and 99% 
for unretained and moderately retained solutes (k” = 3.8, k’ = 2), respectively. Therefore, a 
capillary HPLC column followed by a  CTR with a manageable radius (larger than 12.5 µ m) 
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gives the best column efficiency for moderately or strongly retained solutes at high pressure 
coupled with high temperature. 
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Supplemental Information 
Derivation of reaction rate (k) 
1. The moles of internal standard (IS) collected 
𝑚𝑜𝑙𝐼𝑆 = 𝑈 × 𝑡𝑠 × [𝐼𝑆]       (1) 
Where U is the sampling flow rate, ts is sampling time and [IS] is the initial concentration 
of IS in bath.    
𝑚𝑜𝑙𝐼𝑆 = 𝐴𝐼𝑆/𝑓𝐼𝑆        (2) 
AIS is the peak area of IS and fIS is a calibration factor. Thus, U can be expressed as 
follows, 
𝑈 = 𝐴𝐼𝑆 ([𝐼𝑆] × 𝑡𝑠 × 𝑓𝐼𝑆⁄ )       (3) 
 
2. Exposure time of peptide to tissue, te 
𝑡𝑒 = 𝑉𝑡 𝑈⁄          (4) 
Vt is the volume of tissue sampled. By substituting Eq. (3) and Eq. (2) into Eq. (4), we 
obtained 
𝑡𝑒 = 𝑉𝑡  × 𝑓𝐼𝑆 × 𝑡𝑠 × [𝐼𝑆] 𝐴𝐼𝑆⁄       (5) 
and 
𝑡𝑒 = 𝑉𝑡 × 𝑡𝑠 × [𝐼𝑆]/𝑚𝑜𝑙𝐼𝑆       (5a) 
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3. The moles of substrate/product consumed/produced per unit time with initial rate 
assumption 
𝑘 = 𝑣𝑚𝑎𝑥/(𝐾𝑚 + [𝑠])       (6) 
∆[𝑠]
∆𝑡
= −𝑘[𝑠] = ([𝑠] × 𝑣𝑚𝑎𝑥)/(𝐾𝑚 + [𝑠])     (7) 
Thus, the concentration of substrate leaving the tissue [s]o can be expressed as follows, [𝑠]𝑜 = [𝑠]𝑖 − 𝑘 × [𝑠]𝑖 × 𝑡𝑒       (8) 
or [𝑠]𝑜 = [𝑠]𝑖(1 − 𝑘𝑡𝑒)        (9) 
[s]i  is the concentration of substrate entering into the tissue. 
From Eq. (8) or Eq. (9), we obtained 
𝑘 = (1 − [𝑠]𝑜[𝑠]𝑖) 𝑡𝑒�         (10) [𝑠]𝑜 = 𝑚𝑜𝑙𝑠,𝑜𝑚𝑜𝑙𝐼𝑆/[𝐼𝑆]        (11) 
Here mols,o is the moles of substrate leaving out of the tissue. When substituting Eq. (5a) 
and (11) into Eq. (10), 
𝑘 = 𝑚𝑜𝑙𝐼𝑆[𝐼𝑆]×𝑉𝑡×𝑡𝑠 − 𝑚𝑜𝑙𝑠,0[𝑠]𝑖×𝑉𝑡×𝑡𝑠        (12) 
Therefore, from the decreasing of YGGFL (the substrate) we have 
𝑘 = 𝐴𝐼𝑆
𝑓𝐼𝑆×[𝐼𝑆]×𝑉𝑡×𝑡𝑠 − 𝐴𝑠,𝑜𝑓𝑠×[𝑠]𝑖×𝑉𝑡×𝑡𝑠       (13) 
In Eq. (13), [IS], [s]i, Vt and ts are given experimental conditions. Here we assume the 
sampling volume in the tissue is a cylinder. AIS, As,o, fIS and fs can be obtained from the 
analysis of chromatographs of  standard and sample solutions. Thus, k can be calculated. 
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Similarly, from the increasing of GGFL (the product) we have 
𝑘 = 𝐴𝑝
𝑓𝑝×[𝑠]𝑖×𝑉𝑡×𝑡𝑠        (14) 
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Appendix  
List of Variables - Greek 
εe extra particle porosity, 0.4 
εi  intraparticle porosity, 0.4 
η viscosity of the mobile phase 
λ  numerical geometry-dependent constant,  set to 2  
2
,tcσ   variance from a column in units of time squared 
2
,trσ  variance from a CTR in the units of time squared 
φ  column permeability, set to 750  
 
List of Variables - Roman 
ac column radius, set to 50 µm 
ar the radius of the capillary reactor 
D diffusion coefficient of solute in mobile phase 
dp packing particle diameter 
g numerical geometry-dependent constant, set to 30 (spherical particles)  
H0 the height equivalent to a theoretical plate without a CTR  
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Hc the height equivalent to a theoretical plate  
Hr  height equivalent to a theoretical plate in a CTR 
k0 constant, eiek εεε /)1(0 −=    
k’  the retention factor 
k”  zone retention factor, k” = k0+ (1+k0)k’ 
L0 length of a column without a CTR  
Lc length of a capillary column 
Lr length of a CTR 
Nobs observed number of theoretical plates from a column and a CTR 
N0  number of theoretical plates from a column alone 
Pm maximum pressure provided by HPLC pump 
T  temperature 
t0 dead time of an ananlysis  
u0 average linear velocity in a column without a CTR  
uc average linear velocity in a column with a CTR 
ue  exraparticle linear velocity 
ue0  extraparticle linear velocity without a CTR 
ur linear velocity in the reactor 
y       a constant describing the degree of mixing by diffusion, set to 2.5 
 
